0001058307 false --12-31 Q3 2021 P1Y 5 P5Y 1 3 0001058307 2021-01-01 2021-09-30 0001058307 OSAT:CommonStockParValue0.0001Member 2021-01-01 2021-09-30 0001058307 OSAT:WarrantsMember 2021-01-01 2021-09-30 0001058307 2021-11-15 0001058307 2021-09-30 0001058307 2020-12-31 0001058307 2021-07-01 2021-09-30 0001058307 2020-07-01 2020-09-30 0001058307 2020-01-01 2020-09-30 0001058307 us-gaap:CommonStockMember 2020-12-31 0001058307 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001058307 us-gaap:RetainedEarningsMember 2020-12-31 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001058307 us-gaap:CommonStockMember 2021-01-01 2021-09-30 0001058307 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-09-30 0001058307 us-gaap:RetainedEarningsMember 2021-01-01 2021-09-30 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-09-30 0001058307 us-gaap:CommonStockMember 2021-09-30 0001058307 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0001058307 us-gaap:RetainedEarningsMember 2021-09-30 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-09-30 0001058307 us-gaap:CommonStockMember 2019-12-31 0001058307 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001058307 us-gaap:RetainedEarningsMember 2019-12-31 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0001058307 2019-12-31 0001058307 us-gaap:CommonStockMember 2020-01-01 2020-09-30 0001058307 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-09-30 0001058307 us-gaap:RetainedEarningsMember 2020-01-01 2020-09-30 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-09-30 0001058307 us-gaap:CommonStockMember 2020-09-30 0001058307 us-gaap:AdditionalPaidInCapitalMember 2020-09-30 0001058307 us-gaap:RetainedEarningsMember 2020-09-30 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-09-30 0001058307 2020-09-30 0001058307 us-gaap:CommonStockMember 2021-06-30 0001058307 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001058307 us-gaap:RetainedEarningsMember 2021-06-30 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001058307 2021-06-30 0001058307 us-gaap:CommonStockMember 2021-07-01 2021-09-30 0001058307 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2021-09-30 0001058307 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2021-09-30 0001058307 us-gaap:CommonStockMember 2020-06-30 0001058307 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001058307 us-gaap:RetainedEarningsMember 2020-06-30 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001058307 2020-06-30 0001058307 us-gaap:CommonStockMember 2020-07-01 2020-09-30 0001058307 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2020-09-30 0001058307 us-gaap:RetainedEarningsMember 2020-07-01 2020-09-30 0001058307 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2020-09-30 0001058307 OSAT:EClipsMediaTechnologiesIncMember 2010-04-20 2010-04-21 0001058307 2014-03-27 2014-03-28 0001058307 2018-03-07 2018-03-08 0001058307 2019-08-18 2019-08-19 0001058307 2021-03-23 2021-03-24 0001058307 2021-05-25 2021-05-26 0001058307 2021-05-25 2021-05-28 0001058307 2021-06-01 2021-06-02 0001058307 2021-06-02 0001058307 OSAT:JuneOfferingMember 2021-06-02 0001058307 OSAT:JuneOfferingMember 2021-06-01 2021-06-02 0001058307 us-gaap:OverAllotmentOptionMember 2021-06-25 2021-06-28 0001058307 srt:MaximumMember 2021-09-30 0001058307 OSAT:USToGBPMember OSAT:ClosingRateMember 2021-01-01 2021-09-30 0001058307 OSAT:USToGBPMember OSAT:QuarterlyAverageRateMember 2021-07-01 2021-09-30 0001058307 OSAT:USToGBPMember OSAT:YearlyAverageRateMember 2021-01-01 2021-09-30 0001058307 OSAT:USToGBPMember OSAT:ClosingRateMember 2020-01-01 2020-09-30 0001058307 OSAT:USToGBPMember OSAT:QuarterlyAverageRateMember 2020-01-01 2020-09-30 0001058307 OSAT:USToGBPMember OSAT:YearlyAverageRateMember 2020-01-01 2020-09-30 0001058307 OSAT:USToGBPMember OSAT:ClosingRateMember 2020-01-01 2020-12-31 0001058307 OSAT:USToGBPMember OSAT:YearlyAverageRateMember 2020-01-01 2020-12-31 0001058307 2020-01-01 2020-12-31 0001058307 us-gaap:FurnitureAndFixturesMember 2021-01-01 2021-09-30 0001058307 us-gaap:ComputerEquipmentMember 2021-01-01 2021-09-30 0001058307 us-gaap:EquipmentMember 2021-01-01 2021-09-30 0001058307 OSAT:AppliquesMember 2021-01-01 2021-09-30 0001058307 us-gaap:SoftwareAndSoftwareDevelopmentCostsMember 2021-01-01 2021-09-30 0001058307 us-gaap:ConvertibleNotesPayableMember 2021-01-01 2021-09-30 0001058307 us-gaap:ConvertibleNotesPayableMember 2020-01-01 2020-09-30 0001058307 OSAT:StockOptionsMember 2021-01-01 2021-09-30 0001058307 OSAT:StockOptionsMember 2020-01-01 2020-09-30 0001058307 OSAT:StockWarrantsMember 2021-01-01 2021-09-30 0001058307 OSAT:StockWarrantsMember 2020-01-01 2020-09-30 0001058307 us-gaap:ConvertibleNotesPayableMember 2020-09-30 0001058307 OSAT:UnitedKingdomOfficeAndWarehouseMember 2021-01-01 2021-09-30 0001058307 OSAT:ContractsMember 2014-12-09 2014-12-10 0001058307 OSAT:OrbsatSatcomCorpMember OSAT:ShortTermLoanAgreementMember 2019-10-09 0001058307 OSAT:OrbsatSatcomCorpMember OSAT:ShortTermLoanAgreementMember 2019-10-08 2019-10-09 0001058307 OSAT:NoteExchangeAgreementMember us-gaap:SeriesBPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember us-gaap:SeriesCPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember us-gaap:SeriesDPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember us-gaap:SeriesFPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember us-gaap:SeriesGPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember us-gaap:SeriesHPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember OSAT:SeriesIPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember OSAT:SeriesJPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember OSAT:SeriesKPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember OSAT:SeriesLPreferredStockMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember 2019-04-29 2019-04-30 0001058307 OSAT:NoteExchangeAgreementMember 2019-04-30 0001058307 OSAT:NotePurchaseAgreementMember OSAT:ConvertiblePromissoryNoteMember 2021-03-05 0001058307 OSAT:NotePurchaseAgreementMember OSAT:ConvertiblePromissoryNoteMember 2021-03-03 2021-03-05 0001058307 OSAT:NotePurchaseAgreementMember OSAT:ConvertiblePromissoryNoteMember srt:MinimumMember 2021-03-03 2021-03-05 0001058307 OSAT:MayTwoThousandNineteenNotesMember 2021-09-30 0001058307 OSAT:MayTwoThousandNineteenNotesMember 2020-12-31 0001058307 OSAT:AugustTwoThousandTwentyNotesMember 2021-09-30 0001058307 OSAT:AugustTwoThousandTwentyNotesMember 2020-12-31 0001058307 OSAT:DecemberTwoThousandTwentyNotesMember 2021-09-30 0001058307 OSAT:DecemberTwoThousandTwentyNotesMember 2020-12-31 0001058307 OSAT:MarchTwoThousandTwentyOneNotesMember 2021-09-30 0001058307 OSAT:MarchTwoThousandTwentyOneNotesMember 2020-12-31 0001058307 OSAT:HoldersMember 2021-01-01 2021-09-30 0001058307 OSAT:HoldersMember 2020-01-01 2020-09-30 0001058307 OSAT:HoldersMember OSAT:ConversionRate0.50Member 2020-01-01 2020-09-30 0001058307 OSAT:HoldersMember OSAT:ConversionRate0.50Member 2020-09-30 0001058307 OSAT:HoldersMember OSAT:ConversionRate0.20Member 2020-01-01 2020-09-30 0001058307 OSAT:HoldersMember OSAT:ConversionRate0.20Member 2020-09-30 0001058307 OSAT:GlobalTelesatCommunicationsLimitedMember srt:MaximumMember 2020-04-18 2020-04-20 0001058307 OSAT:CoronavirusLoansMember OSAT:LendersMember 2020-07-14 2020-07-16 0001058307 OSAT:CoronavirusLoansMember OSAT:LendersMember OSAT:USToGBPMember 2020-07-16 0001058307 OSAT:CoronavirusLoansMember OSAT:FirstRepaymentMember 2020-07-16 0001058307 OSAT:CoronavirusLoansMember 2021-09-30 0001058307 OSAT:PayrollProtectionProgramMember OSAT:CoronavirusLoansMember 2020-05-07 2020-05-08 0001058307 OSAT:PayrollProtectionProgramMember OSAT:CoronavirusLoansMember 2020-05-08 0001058307 OSAT:PayrollProtectionProgramMember OSAT:CoronavirusLoansMember 2021-05-22 2021-05-23 0001058307 2016-03-05 0001058307 2016-03-04 0001058307 2019-07-23 2019-07-24 0001058307 2019-07-24 0001058307 us-gaap:CommonStockMember 2021-05-25 2021-05-28 0001058307 us-gaap:CommonStockMember OSAT:ReverseSplitMember 2021-05-25 2021-05-28 0001058307 us-gaap:WarrantMember 2021-09-30 0001058307 us-gaap:WarrantMember 2021-06-02 0001058307 us-gaap:WarrantMember us-gaap:CommonStockMember 2021-06-01 2021-06-02 0001058307 us-gaap:WarrantMember us-gaap:CommonStockMember 2021-06-09 2021-06-10 0001058307 us-gaap:WarrantMember 2021-06-09 2021-06-10 0001058307 us-gaap:WarrantMember 2021-06-10 0001058307 us-gaap:WarrantMember us-gaap:CommonStockMember 2021-06-27 2021-06-28 0001058307 us-gaap:WarrantMember us-gaap:CommonStockMember 2021-06-28 0001058307 us-gaap:WarrantMember us-gaap:CommonStockMember 2021-06-28 0001058307 us-gaap:CommonStockMember us-gaap:WarrantMember 2021-07-05 2021-07-06 0001058307 us-gaap:WarrantMember 2021-07-05 2021-07-06 0001058307 us-gaap:WarrantMember 2021-07-06 0001058307 us-gaap:CommonStockMember us-gaap:WarrantMember 2021-07-07 2021-07-08 0001058307 us-gaap:WarrantMember 2021-07-07 2021-07-08 0001058307 us-gaap:WarrantMember 2021-07-08 0001058307 us-gaap:CommonStockMember us-gaap:WarrantMember 2021-07-11 2021-07-12 0001058307 us-gaap:WarrantMember 2021-07-11 2021-07-12 0001058307 us-gaap:WarrantMember 2021-07-12 0001058307 us-gaap:CommonStockMember us-gaap:WarrantMember 2021-07-11 2021-07-13 0001058307 us-gaap:WarrantMember 2021-07-11 2021-07-13 0001058307 us-gaap:WarrantMember 2021-07-13 0001058307 us-gaap:CommonStockMember us-gaap:WarrantMember 2021-07-11 2021-07-14 0001058307 us-gaap:WarrantMember 2021-07-11 2021-07-14 0001058307 us-gaap:WarrantMember 2021-07-14 0001058307 us-gaap:CommonStockMember us-gaap:WarrantMember 2021-07-17 2021-07-19 0001058307 us-gaap:WarrantMember 2021-07-17 2021-07-19 0001058307 us-gaap:WarrantMember 2021-07-19 0001058307 us-gaap:CommonStockMember us-gaap:WarrantMember 2021-07-28 2021-07-30 0001058307 us-gaap:WarrantMember 2021-07-28 2021-07-30 0001058307 us-gaap:WarrantMember 2021-07-30 0001058307 OSAT:MaximGroupLLCMember OSAT:UnderwriterWarrantsMember 2021-09-30 0001058307 OSAT:MaximGroupLLCMember OSAT:UnderwriterWarrantsMember 2021-06-10 0001058307 OSAT:MaximGroupLLCMember OSAT:UnderwriterWarrantsMember 2021-01-01 2021-09-30 0001058307 OSAT:UnderwriterWarrantsMember 2021-09-30 0001058307 OSAT:BoardOfDirectorsMember 2021-02-18 2021-02-19 0001058307 OSAT:BoardOfDirectorsMember 2021-02-19 0001058307 us-gaap:CommonStockMember 2021-01-11 2021-01-12 0001058307 us-gaap:CommonStockMember 2021-01-12 0001058307 us-gaap:CommonStockMember 2021-02-21 2021-02-23 0001058307 us-gaap:CommonStockMember 2021-02-23 0001058307 OSAT:CommonStock1Member 2021-02-21 2021-02-23 0001058307 OSAT:CommonStock1Member 2021-02-23 0001058307 us-gaap:CommonStockMember 2021-03-01 2021-03-02 0001058307 us-gaap:CommonStockMember 2021-03-02 0001058307 OSAT:CommonStock1Member 2021-03-01 2021-03-02 0001058307 OSAT:CommonStock1Member 2021-03-02 0001058307 OSAT:CommonStock1Member 2021-03-23 2021-03-24 0001058307 OSAT:CommonStock1Member 2021-05-19 2021-05-20 0001058307 us-gaap:CommonStockMember 2021-05-20 0001058307 OSAT:CommonStock1Member 2021-05-25 2021-05-27 0001058307 us-gaap:CommonStockMember 2021-05-27 0001058307 OSAT:UnderwriterMember OSAT:MaximGroupLLCMember 2021-05-25 2021-05-28 0001058307 OSAT:UnderwriterMember OSAT:MaximGroupLLCMember 2021-05-28 0001058307 OSAT:UnderwriterMember OSAT:MaximGroupLLCMember us-gaap:CommonStockMember 2021-05-25 2021-05-28 0001058307 OSAT:UnderwriterMember OSAT:MaximGroupLLCMember us-gaap:WarrantMember 2021-05-28 0001058307 OSAT:UnderwriterMember OSAT:MaximGroupLLCMember us-gaap:CommonStockMember 2021-05-28 0001058307 OSAT:UnderwriterMember OSAT:MaximGroupLLCMember 2021-06-25 2021-06-28 0001058307 OSAT:UnderwriterWarrantMember 2021-06-10 0001058307 us-gaap:CommonStockMember 2021-06-09 2021-06-10 0001058307 us-gaap:CommonStockMember 2021-06-10 0001058307 us-gaap:CommonStockMember 2021-07-05 2021-07-06 0001058307 us-gaap:CommonStockMember 2021-07-06 0001058307 us-gaap:CommonStockMember 2021-07-07 2021-07-08 0001058307 us-gaap:CommonStockMember 2021-07-08 0001058307 us-gaap:CommonStockMember 2021-07-11 2021-07-12 0001058307 us-gaap:CommonStockMember 2021-07-12 0001058307 us-gaap:CommonStockMember 2021-07-11 2021-07-13 0001058307 us-gaap:CommonStockMember 2021-07-13 0001058307 us-gaap:CommonStockMember 2021-07-11 2021-07-14 0001058307 us-gaap:CommonStockMember 2021-07-14 0001058307 us-gaap:CommonStockMember 2021-07-11 2021-07-15 0001058307 us-gaap:CommonStockMember 2021-07-17 2021-07-19 0001058307 us-gaap:CommonStockMember 2021-07-19 0001058307 us-gaap:CommonStockMember 2021-07-28 2021-07-30 0001058307 us-gaap:CommonStockMember 2021-07-30 0001058307 us-gaap:CommonStockMember 2021-09-01 2021-09-03 0001058307 us-gaap:CommonStockMember 2021-09-03 0001058307 us-gaap:CommonStockMember 2021-09-12 2021-09-14 0001058307 us-gaap:CommonStockMember 2021-09-14 0001058307 us-gaap:CommonStockMember 2021-09-20 2021-09-22 0001058307 us-gaap:CommonStockMember 2021-09-22 0001058307 OSAT:DouglasEllenoffChiefBusinessDevelopmentStrategistMember 2021-08-22 2021-08-24 0001058307 OSAT:PaulRThomsonExecutiveVicePresidentAndChiefFinancialOfficerMember 2021-08-22 2021-08-24 0001058307 2021-08-22 2021-08-24 0001058307 2021-08-24 0001058307 OSAT:MeasurementInputExpectedVolatilityMember 2021-08-24 0001058307 us-gaap:MeasurementInputExpectedTermMember 2021-08-22 2021-08-24 0001058307 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-08-24 0001058307 OSAT:PaulRThomsonExecutiveVicePresidentAndChiefFinancialOfficerMember 2021-01-01 2021-09-30 0001058307 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember OSAT:PaulRThomsonExecutiveVicePresidentAndChiefFinancialOfficerMember 2021-08-22 2021-08-24 0001058307 us-gaap:RestrictedStockUnitsRSUMember OSAT:PaulRThomsonExecutiveVicePresidentAndChiefFinancialOfficerMember 2021-08-22 2021-08-24 0001058307 us-gaap:RestrictedStockUnitsRSUMember OSAT:PaulRThomsonExecutiveVicePresidentAndChiefFinancialOfficerMember 2021-08-24 0001058307 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember OSAT:DouglasEllenoffChiefBusinessDevelopmentStrategistMember 2021-08-22 2021-08-24 0001058307 us-gaap:RestrictedStockUnitsRSUMember OSAT:DouglasEllenoffChiefBusinessDevelopmentStrategistMember 2021-08-22 2021-08-24 0001058307 us-gaap:RestrictedStockUnitsRSUMember OSAT:DouglasEllenoffChiefBusinessDevelopmentStrategistMember 2021-08-24 0001058307 OSAT:DouglasEllenoffChiefBusinessDevelopmentStrategistMember 2021-01-01 2021-09-30 0001058307 OSAT:DouglasEllenoffChiefBusinessDevelopmentStrategistMember 2021-08-24 0001058307 OSAT:DavidPhippsMember 2021-09-30 0001058307 OSAT:CharlesMFernandezMember 2021-09-30 0001058307 OSAT:SarwarUddinMember 2021-09-30 0001058307 OSAT:TheresaCarliseMember 2021-09-30 0001058307 OSAT:PaulThomsonMember 2021-09-30 0001058307 OSAT:HSBCMember 2021-01-01 2021-09-30 0001058307 OSAT:HSBCMember 2021-09-30 0001058307 OSAT:ThreeIndividualsRelatedToMrPhippsMember 2021-01-01 2021-09-30 0001058307 OSAT:ThreeIndividualsRelatedToMrPhippsMember 2020-01-01 2020-09-30 0001058307 OSAT:EmploymentAgreementsMember OSAT:DavidPhippsMember 2021-06-04 2021-06-05 0001058307 OSAT:EmploymentAgreementsMember OSAT:DavidPhippsMember 2021-08-06 2021-08-07 0001058307 OSAT:FernandezAgreementMember OSAT:CharlesMFernandezMember 2021-05-22 2021-05-23 0001058307 OSAT:FernandezAgreementMember OSAT:CharlesMFernandezMember srt:MaximumMember 2021-05-22 2021-05-23 0001058307 OSAT:JuneAgreementMember OSAT:CharlesMFernandezMember 2021-05-29 2021-06-02 0001058307 OSAT:JuneAgreementMember OSAT:CharlesMFernandezMember srt:MaximumMember 2021-05-29 2021-06-02 0001058307 OSAT:JuneAgreementMember OSAT:CharlesMFernandezMember 2021-06-02 0001058307 OSAT:JuneAgreementMember OSAT:CharlesMFernandezMember 2021-08-06 2021-08-07 0001058307 OSAT:UddinEmploymentAgreementMember OSAT:SarwarUddinMember 2021-06-20 2021-06-22 0001058307 OSAT:UddinEmploymentAgreementMember OSAT:SarwarUddinMember 2021-08-06 2021-08-07 0001058307 OSAT:CarliseEmploymentAgreementMember OSAT:TheresaCarliseMember 2021-06-20 2021-06-22 0001058307 us-gaap:SubsequentEventMember OSAT:CarliseEmploymentAgreementMember OSAT:TheresaCarliseMember srt:MinimumMember 2021-10-01 2021-10-08 0001058307 us-gaap:SubsequentEventMember OSAT:CarliseEmploymentAgreementMember OSAT:TheresaCarliseMember srt:MaximumMember 2021-10-01 2021-10-08 0001058307 OSAT:EmploymentAgreementsMember OSAT:EllenoffMember 2021-08-01 2021-08-24 0001058307 OSAT:EmploymentAgreementsMember OSAT:EllenoffMember 2021-08-24 0001058307 OSAT:EmploymentAgreementsMember OSAT:ThomsonMember 2021-08-01 2021-08-24 0001058307 OSAT:LeaseAgreementMember 2019-07-24 0001058307 OSAT:LeaseAgreementMember 2019-07-23 2019-07-24 0001058307 OSAT:YearlyAverageRateMember 2020-01-01 2020-12-31 0001058307 OSAT:LeaseAgreementMember 2021-06-20 2021-06-21 0001058307 OSAT:LeaseAgreementMember 2021-08-12 0001058307 OSAT:LeaseAgreementMember 2021-08-01 2021-08-12 0001058307 OSAT:LeaseAgreementMember 2021-01-01 2021-09-30 0001058307 OSAT:LeaseAgreementMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OSAT:AmazonMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OSAT:AmazonMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OSAT:AmazonMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember OSAT:AmazonMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:SatcomGlobalMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:SatcomGlobalMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:GlobalstarEuropeMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:GlobalstarEuropeMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:GarminMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:GarminMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:NetworkInnovationsMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:NetworkInnovationsMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:CygnusTelecomMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:CygnusTelecomMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:SatcomGlobalMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:SatcomGlobalMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:GlobalstarEuropeMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:GlobalstarEuropeMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:GarminMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:GarminMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:NetworkInnovationsMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:NetworkInnovationsMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:CygnusTelecomMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:SupplierConcentrationRiskMember OSAT:CygnusTelecomMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:EuropeMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:EuropeMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:NorthAmericaMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:NorthAmericaMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:SouthAmericaMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:SouthAmericaMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:AsiaPacificMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:AsiaPacificMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:AfricaMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:AfricaMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-01-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-01-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:EuropeMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:EuropeMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:NorthAmericaMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:NorthAmericaMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:SouthAmericaMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:SouthAmericaMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:AsiaPacificMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:AsiaPacificMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:AfricaMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember srt:AfricaMember 2020-07-01 2020-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2021-07-01 2021-09-30 0001058307 us-gaap:SalesRevenueNetMember us-gaap:GeographicConcentrationRiskMember 2020-07-01 2020-09-30 0001058307 us-gaap:SubsequentEventMember OSAT:EmploymentAgreementsMember OSAT:AndrewCohenMember 2021-10-01 2021-10-08 0001058307 us-gaap:SubsequentEventMember OSAT:EmploymentAgreementsMember OSAT:AndrewCohenMember 2021-10-07 0001058307 us-gaap:SubsequentEventMember OSAT:EmploymentAgreementsMember OSAT:AndrewCohenMember srt:MinimumMember 2021-10-01 2021-10-08 0001058307 us-gaap:SubsequentEventMember OSAT:EmploymentAgreementsMember OSAT:AndrewCohenMember srt:MaximumMember 2021-10-01 2021-10-08 0001058307 us-gaap:SubsequentEventMember 2021-10-01 2021-10-21 iso4217:USD xbrli:shares iso4217:USD xbrli:shares iso4217:GBP utr:sqft OSAT:Integer xbrli:pure

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2021

 

OR

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT

 

For the transition period from ______________to _______________.

 

Commission File Number 001-40447

 

ORBSAT CORP
(Exact name of registrant as specified in its charter)

 

Nevada   65-0783722

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

     

18851 NE 29th Avenue, Suite 700

Aventura, FL

  33180
(Address of principal executive offices   (Zip Code)

 

(305)-560-5355
Registrant’s telephone number, including area code

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001   OSAT   The Nasdaq Stock Market LLC
Warrants   OSATW   The Nasdaq Stock Market LLC

 

Indicate by check whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined by Rule 12b-2 of the Exchange Act). Yes ☐ No

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock as of the latest practicable date.

 

Class   Outstanding at November 15, 2021
Common Stock, $0.0001 par value   6,479,263

 

 

 

 

 

 

FORM 10-Q

 

INDEX

 

  Page
   
PART I: FINANCIAL INFORMATION  
   
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED) 2
   
CONDENSED CONSOLIDATED BALANCE SHEETS 2
   
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 3
   
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY 4
   
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS 6
   
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS 7
   
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 30
   
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 40
   
ITEM 4. CONTROLS AND PROCEDURES 40
   
PART II. OTHER INFORMATION  
   
ITEM 1. LEGAL PROCEEDINGS 41
   
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 41
   
ITEM 3 DEFAULTS UPON SENIOR SECURITIES 41
   
ITEM 4. MINE SAFETY DISCLOSURES 41
   
ITEM 5. OTHER INFORMATION 41
   
ITEM 6. EXHIBITS 42
   
SIGNATURES 43

 

i

 

 

Part I Financial Information

 

Item 1. Financial Statements

 

The unaudited financial statements of Orbsat Corp (“Orbsat,” the “Company,” “we,” or “our”), for the nine months ended September 30, 2021 and for comparable periods in the prior year are included below. The financial statements should be read in conjunction with the notes to financial statements that follow.

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS AS OF

 

   September 30, 2021   December 31, 2020 
    (unaudited)      
ASSETS          
Current assets:          
Cash  $17,138,644   $728,762 
Accounts receivable, net   309,839    177,031 
Inventory   982,909    361,422 
Unbilled revenue   97,909    75,556 
VAT receivable   446,657    - 
Prepaid expenses   8,653    1,784 
Other current assets   28,640    27,912 
Total current assets  $19,013,251    1,372,467 
           
Property and equipment, net   995,157    1,106,164 
Right of use   30,658    55,606 
Intangible assets, net   81,250    100,000 
Prepaid expenses – long term portion   38,706    - 
           
Total assets  $20,159,022   $2,634,237 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
           
Current liabilities:          
Accounts payable and accrued liabilities  $884,046   $1,052,603 
Contract liabilities   40,956    36,704 
Note payable – current portion   -    121,848 
Note payable Coronavirus loans– current portion   55,943    41,831 
Due to related party   67,273    102,060 
Lease liabilities – current   27,801    30,125 
Provision for income taxes   56,560    18,957 
Liabilities from discontinued operations   112,397    112,397 
Total current liabilities   1,244,976    1,516,525 
           
Long term liabilities:          
Convertible debt, net of discount, unamortized, $0 and $1,084,944, respectively   -    209,323 
Note payable Coronavirus loans– long term   268,528    320,626 
Lease liabilities – long term   -    22,574 
Total Liabilities   1,513,504    2,069,048 
           
Stockholders’ Equity:          
Common stock, ($0.0001 par value; 50,000,000 shares authorized, 6,469,263 shares issued and outstanding as of September 30, 2021 and 817,450 shares issued and outstanding at December 31, 2020, respectively)   647    82 
Additional paid-in capital   37,090,491    14,486,492 
Accumulated (deficit)   (18,445,638)   (13,878,553)
Accumulated other comprehensive income (loss)   18    (42,832)
Total stockholders’ equity   18,645,518    565,189 
           
Total liabilities and stockholders’ equity  $20,159,022   $2,634,237 

 

See the accompanying notes to the unaudited condensed consolidated financial statements.

 

2
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE LOSS

 

   Three Months Ended
September 30, 2021
   Three Months Ended
September 30, 2020
   Nine Months Ended
September 30, 2021
   Nine Months Ended
September 30, 2020
 
Net sales  $2,250,278   $1,475,393   $5,667,966   $4,163,750 
                     
Cost of sales   1,757,142    1,076,929    4,195,823    3,159,593 
                     
Gross profit   493,136    398,464    1,472,143    1,004,157 
                     
Operating expenses:                    
Selling and general administrative   519,196    182,813    962,892    486,984 
Salaries, wages and payroll taxes   490,555    196,629    1,178,267    542,675 
Stock based compensation   1,321,564    130,400    1,321,564    130,400 
Professional fees   320,211    289,296    869,127    480,961 
Depreciation and amortization   78,456    73,697    225,404    217,992 
Total operating expenses   2,729,982    872,835    4,557,254    1,859,012 
                     
Loss before other expenses and income taxes   (2,236,846)   (474,371)   (3,085,111)   (854,855)
                     
Other (income) expense                    
Other income   -    (268)   -    (31,793)
Gain on debt extinguishment   -   -    (20,832)   (269,261)
Interest earned   (3,146)   (67)   (3,146)   (80)
Interest expense   2,385    641,460    1,463,986    797,807 
Foreign currency exchange rate variance   69,464    (15,045)   41,966    7,217 
Total other (income) expense   68,703    626,080    1,481,974    503,890 
                     
Net (loss) income before tax expense  $(2,305,549)  $(1,100,451)  $(4,567,085)  $(1,358,745)
                     
Provision for income taxes   -    -    -    - 
                     
Net (loss) income   (2,305,549)   (1,100,451)   (4,567,085)   (1,358,745)
                     
Comprehensive income (loss):                    
Net (loss) income   (2,305,549)   (1,100,451)   (4,567,085)   (1,358,745)
Foreign currency translation adjustments   55,584    5,602    42,850    (19,840)
Comprehensive income (loss)  $(2,249,965)  $(1,094,849)  $(4,524,235)  $(1,378,585)
                     
NET (LOSS) INCOME ATTRIBUTABLE TO COMMON STOCKHOLDERS                    
Weighted number of common shares outstanding – basic & diluted   6,290,306    154,634    3,271,405    99,027 
Basic and diluted net (loss) income per share  $(0.37)  $(7.12)  $(1.40)  $(13.72)

 

See the accompanying notes to the unaudited condensed consolidated financial statements.

 

3
 

 

ORBSAT CORP. AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

 

For the Nine months Ended September 30, 2021

 

                         
   Common Stock
$0.0001 Par Value
   Additional
Paid in
   Accumulated   Comprehensive   Stockholders’ 
   Shares   Amount   Capital   Deficit   Income (Loss)   Equity 
                         
Balance, December 31, 2020   817,450   $82   $14,486,492   $(13,878,553)  $(42,832)  $565,189 
                               
Issuance common stock from convertible debt   1,345,468    135    1,644,132    -    -    1,644,267 
Issuance of common related to offering   2,880,000    288    12,661,696    -    -    12,661,984 
Issuance of common for over-allotment   432,000    43    1,983,226    -    -    1,983,269 
Issuance of warrants for over-allotment   -    -    4,320    -    -    4,320 
Issuance of common stock from exercise of warrant   925,908    92    4,629,448    -    -    4,629,540 
Issuance of common stock for exercise of options   17,437    2    4,998    -    -    5,000 
Stock based compensation in connection with options granted   -    -    1,053,064    -    -    1,053,064 
Stock based compensation in connection with restricted stock awards   50,000    5    268,495    -    -    268,500 
Issuance of common stock for services   1,000    -    14,200    -    -    14,200 
Beneficial conversion feature of convertible debt   -    -    340,420    -    -    340,420 
Comprehensive loss   -    -    -    -    42,850    42,850 
                               
Net loss   -    -    -    (4,567,085)   -    (4,567,085)
                               
Balance, September 30, 2021   6,469,263   $647   $37,090,491   $(18,445,638)  $18   $18,645,518 

 

For the Nine months Ended September 30, 2020

 

   Common Stock
$0.0001 Par Value
   Additional
Paid in
   Accumulated   Comprehensive   Stockholders’ 
   Shares   Amount   Capital   Deficit   Income (Loss)   Equity 
                         
Balance, December 31, 2019   24,243   $2   $11,757,037   $(11,115,178)  $(2,152)  $639,709 
                             - 
Issuance common stock from convertible debt   597,657    60    585,529    -    -    585,589 
Issuance of common stock for options exercised   85,960    9    32,991    -    -    33,000 
Stock issued for services   5,000    -    62,750    -    -    62,750 
Stock based compensation in connection with options granted   -    -    130,400    -    -    130,400 
Beneficial conversion feature of convertible debt   -    -    898,918    -    -    

898,918

 
Comprehensive loss   -    -    -    -    (19,840)   (19,840)
Net loss   -    -    -    (1,358,745)   -    (1,358,745)
                             - 
Balance, September 30, 2020   712,860   $71   $13,467,625   $(12,473,923)  $(21,992)  $971,781 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

4
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ EQUITY

 

For the Three Months Ended September 30, 2021

 

   Common Stock
$0.0001 Par Value
   Additional
Paid in
   Accumulated   Comprehensive   Stockholders’ 
   Shares   Amount   Capital   Deficit   Income (Loss)   Equity 
                         
Balance, June 30, 2021   5,476,918   $548   $31,139,486   $(16,140,089)  $(55,566)  $14,944,379 
                               
Issuance of common stock related to exercise of options   17,437    2    4,998    -    -    5,000 
Stock based compensation for restricted stock awards   50,000    5    268,495    -    -    268,500 
Stock based compensation for options granted   -    -    1,053,064    -    -    1,053,064 
Issuance of common stock from exercise warrant   924,908    92    4,624,448    -    -    4,624,540 
Comprehensive income   -    -    -    -    55,584    55,584 
Net loss   -    -    -    (2,305,549)   -    (2,305,549)
                               
Balance, September 30, 2021   6,469,263   $647   $37,090,491   $(18,445,638)  $18   $18,645,518 

 

For the Three Months Ended September 30, 2020

 

   Common Stock
$0.0001 Par Value
   Additional
Paid in
   Accumulated   Comprehensive   Stockholders’ 
   Shares   Amount   Capital   Deficit   Income (Loss)   Equity 
                         
Balance, June 30, 2020   51,066   $5   $11,771,789   $(11,373,472)  $(11,018)  $387,304 
                               
Issuance common stock from convertible debt   570,834    57    570,777    -    -    570,834 
Issuance of common stock related to exercise of options   85,960    9    32,991    -    -    33,000 
Stock issued for services   5,000    -    62,750    -    -    62,750 
Stock based compensation for options granted   -    -    130,400    -    -    130,400 
Beneficial conversion feature of convertible debt   -    -    898,918    -    -    898,918 
Comprehensive loss   -    -    -    -    (10,974)   (10,974)
Net loss   -    -    -    (1,100,451)   -    (1,100,451)
                               
Balance, September 30, 2020   712,860   $71    13,467,625   $(12,473,923)  $(21,992)  $971,781 

 

See accompanying notes to unaudited condensed consolidated financial statements.

 

5
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE NINE MONTHS ENDED

 

   September 30, 2021   September 30, 2020 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(4,567,085)  $(1,358,745)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation expense   206,654    199,242 
Amortization of intangible asset   18,750    18,750 
Stock based compensation   1,321,564    

130,400

 
Stock issued for services   14,200    

62,750

 
Amortization of right to use   24,948    23,773 
Amortization of convertible debt discount, net   1,425,365    752,130 
Gain on debt extinguishment   (20,832)   (269,261)
Change in operating assets and liabilities:          
Accounts receivable   (132,808)   81,739 
Inventory   (621,487)   (135,648)
Unbilled revenue   (22,353)   877 
VAT receivable   (446,657)   - 
Prepaid expense   (45,575)   16,812 
Other current assets   (728)   57,800 
Accounts payable and accrued liabilities   (168,557)   (61,747)
Lease liabilities   (24,898)   (21,562)
Provision for income taxes   37,603    (1,330)
Contract liabilities   4,252    (780)
Net cash used in operating activities   (2,997,644)   (504,800)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (95,598)   (30,752)
Net cash used in investing activities   (95,598)   (30,752)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from convertible note payable   350,000    958,000 
Proceeds from related party payable   34,238    - 
Proceeds from common stock offering   12,661,984    - 
Proceeds from warrant offering   1,987,589    - 
Proceeds from exercise of warrant   4,629,540    - 
Proceeds from exercise of options   5,000    

33,000

 
Proceeds of note payable   -    343,907 
Repayments of line of credit   -    (19,685)
Repayments of related party payable   (69,025)   

(18,889

)
Repayments of note payable   (121,848)   - 
Repayments of Coronavirus note payable   (11,189)   - 
          
Net cash provided by financing activities   19,466,289    1,296,333 
           
Effect of exchange rate on cash   36,835    (19,130)
           
Net increase in cash   16,409,882    741,651 
Cash beginning of period   728,762    75,362 
Cash end of period  $17,138,644   $817,013 
           
SUPPLEMENTAL CASH FLOW INFORMATION          
Cash paid during the period for          
Interest  $144,187   $- 
Income tax  $-   $- 
Non-cash adjustments during the period for          
Beneficial conversion feature on convertible debt  $340,420   $898,918 
Conversion of convertible debt into common shares  $1,644,267   $585,589 
Obtaining right of use asset for lease liability  $-   $59,906 

 

See the accompanying notes to the unaudited condensed consolidated financial statements.

 

6
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying unaudited condensed consolidated interim financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial statements and do not include all the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements. The information furnished reflects all adjustments, consisting only of normal recurring items which are, in the opinion of management, necessary in order to make the financial statements not misleading. The unaudited financial statements for the nine months ending September 30, 2021, are not necessarily indicative of the results for the remainder of the fiscal year. The consolidated financial statements as of December 31, 2020, have been audited by an independent registered public accounting firm. The accounting policies and procedures employed in the preparation of these condensed consolidated financial statements have been derived from the audited financial statements of Orbsat Corp F/K/A/ Orbital Tracking Corp. (the “Company”) for the year ended December 31, 2020, which are contained in the Company’s annual report on Form 10-K as filed with the Securities and Exchange Commission (the “SEC”) on March 22, 2021. The consolidated balance sheet as of December 31, 2020 was derived from those financial statements.

 

Basis of Presentation and Principles of Consolidation

 

The consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States of America (“US GAAP”). The consolidated financial statements of the Company include the Company and its wholly-owned subsidiaries, Orbital Satcom Corp. (“Orbital Satcom”) and Global Telesat Communications Limited (“GTC”). All material intercompany balances and transactions have been eliminated in consolidation.

 

Description of Business

 

Orbsat Corp is a provider of satellite-based hardware, airtime and related services both in the United States and internationally. The Company’s principal focus is on growing the Company’s existing satellite-based hardware, airtime and related services business line and developing the Company’s own tracking devices for use by retail customers worldwide.

 

The Company was originally incorporated in 1997 in Florida. On April 21, 2010, the Company merged with and into a wholly-owned subsidiary for the purpose of changing its state of incorporation to Delaware, effecting a 2:1 forward split of its common stock, and changing its name to EClips Media Technologies, Inc. On April 25, 2011, the Company changed its name to Silver Horn Mining Ltd. pursuant to a merger with a wholly-owned subsidiary.

 

GTC was formed under the laws of England and Wales in 2008. On February 19, 2015, we entered into a share exchange agreement with GTC and all of the holders of the outstanding equity of GTC pursuant to which GTC became a wholly owned subsidiary of ours.

 

On March 28, 2014, we merged with a newly-formed wholly-owned subsidiary of ours solely for the purpose of changing our state of incorporation to Nevada from Delaware, effecting a 1:150 reverse split of our common stock, and changing our name to Great West Resources, Inc. in connection with the plans to enter into the business of potash mining and exploration. During late 2014, we abandoned our efforts to enter the potash business.

 

Orbital Satcom, a Nevada corporation was formed on November 14, 2014.

 

On January 22, 2015, we changed our name to “Orbital Tracking Corp” from “Great West Resources, Inc.” pursuant to a merger with a newly formed wholly owned subsidiary.

 

Effective March 8, 2018, following the approval of a majority of our shareholders, we effected a reverse split of our common stock at a ratio of 1 for 150. On August 19, 2019, we effected a reverse split of our common stock at a ratio of 1 for 15. As a result of the reverse split, our common stock now has the CUSIP number: 68557F100. All share and per share, information in the accompanying consolidated financial statements and footnotes has been retroactively restated to reflect these reverse splits.

 

Also, on August 19, 2019, we changed our name to “Orbsat Corp.” from “Orbital Tracking Corp.” pursuant to a merger with a newly formed wholly owned subsidiary.

 

On March 24, 2021, the Company’s shareholders via majority shareholder consent authorized a stock split not to exceed 1 for 5 reverse stock split. A definitive Information Statement relating to the shareholder consent was filed with the SEC on March 13, 2021. The Company’s Board of Directors (the “Board”) subsequently approved a 1-for-5 reverse stock split. The Company filed a Certificate of Change to its Amended and Restated Articles of Incorporation to effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-5. The effective time of the reverse stock split was 12:01 a.m. ET on May 28, 2021. The Company’s common stock began trading on a split-adjusted basis commencing upon market open on May 28, 2021. The common stock has been assigned a new CUSIP number, 68557F 209. The warrants were assigned the CUSIP number, 68557F 118. No fractional shares of common stock were issued as a result of the reverse stock split. Stockholders of record who would otherwise be entitled to receive a fractional share received a whole share.

 

All information presented in this Quarterly Report on Form 10-Q other than in Company’s consolidated financial statements and the notes thereto assumes a 1-for-5 reverse stock split of Company’s outstanding shares of common stock and unless otherwise indicated, all such amounts and corresponding conversion price or exercise price data set forth in this Quarterly Report on Form 10-Q have been adjusted to give effect to such assumed reverse stock split.

 

On May 28, 2021, our common stock and Warrants commenced trading on Nasdaq under the symbols “OSAT” and “OSATW,” respectively

 

7
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Global Telesat Communications Limited (“GTC”) was formed under the laws of England and Wales in 2008. On February 19, 2015, the Company entered into a share exchange agreement with GTC and all of the holders of the outstanding equity of GTC pursuant to which GTC became a wholly-owned subsidiary of the Company.

 

Liquidity

 

As an early-stage growth company, Orbsat’s ability to access capital is critical. On June 2, 2021, through an upsized underwritten public offering of 2,880,000 units at a price to the public of $5.00 per unit, the Company received gross proceeds of $14,400,000 (the “June Offering”). See Note 12, Stockholders’ Equity, for more information regarding the June Offering.

 

In connection with closing of the June Offering, the Underwriter partially exercised its overallotment option and purchased an additional 432,000 warrants at $0.01 per warrant for additional gross proceeds to the Company of $4,320. On June 28, 2021, the Underwriter, upon the exercise in full of the balance of its over-allotment option, purchased 432,000 additional shares of the common stock for additional gross proceeds of $2,155,680 from the sale of the Shares. Orbsat management has plans to raise additional capital in 2021.

 

As of the date of this report, the Company’s existing cash resources and existing borrowing availability are sufficient to support planned operations for the next 12 months. As a result, management believes that the Company’s existing financial resources are sufficient to continue operating activities for at least one year past the issuance date of the financial statements.

 

These financial statements have been prepared by management in accordance with GAAP and this basis assumes that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. These financial statements do not include any adjustments that may result from the outcome of this uncertainty.

 

Use of Estimates

 

In preparing the consolidated financial statements, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the statements of financial condition, and revenues and expenses for the years then ended. Actual results may differ significantly from those estimates. Significant estimates made by management include, but are not limited to, the assumptions used to calculate stock-based compensation, derivative liabilities and common stock issued for services.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with a maturity of three months or less when acquired to be cash equivalents. The Company places its cash with a high credit quality financial institution. The Company’s account at this institution is insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $250,000. All cash amounts in excess of $250,000, $16,888,644, are unsecured. To reduce its risk associated with the failure of such financial institution, the Company evaluates at least annually the rating of the financial institution in which it holds deposits.

 

Accounts receivable and allowance for doubtful accounts

 

The Company has a policy of reserving for questionable accounts based on its best estimate of the amount of probable credit losses in its existing accounts receivable. The Company periodically reviews its accounts receivable to determine whether an allowance is necessary based on an analysis of past due accounts and other factors that may indicate that the realization of an account may be in doubt. Account balances deemed to be uncollectible are offset against sales and relieved from accounts receivable, after all means of collection have been exhausted and the potential for recovery is considered remote. As of September 30, 2021, and December 31, 2020, there is an allowance for doubtful accounts of $15,782 and $15,596, respectively.

 

8
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Inventories

 

Inventories are valued at the lower of cost or net realizable value, using the first-in first-out cost method. The Company assesses the valuation of its inventories and reduces the carrying value of those inventories that are obsolete or in excess of the Company’s forecasted usage to their estimated net realizable value. The Company estimates the net realizable value of such inventories based on analysis and assumptions including, but not limited to, historical usage, expected future demand and market requirements. A change to the carrying value of inventories is recorded to cost of goods sold.

 

Prepaid expenses

 

Prepaid expenses amounted to $8,653 at September 30, 2021 and $1,784 at December 31, 2020. Prepaid expense includes prepaid rent of $6,169, as well as cost associated with certain contract liabilities. The current portion consists of costs paid for future services which will occur within a year.

 

Foreign Currency Translation

 

The Company’s reporting currency is U.S. Dollars. The accounts of one of the Company’s subsidiaries, GTC, is maintained using the appropriate local currency, Great British Pound, as the functional currency. All assets and liabilities are translated into U.S. Dollars at balance sheet date, shareholders’ equity is translated at historical rates and revenue and expense accounts are translated at the average exchange rate for the year or the reporting period. The translation adjustments are reported as a separate component of stockholders’ equity, captioned as accumulated other comprehensive (loss) gain. Transaction gains and losses arising from exchange rate fluctuations on transactions denominated in a currency other than the functional currency are included in the statements of operations.

 

The relevant translation rates are as follows: for the three and nine months ended September 30, 2021, closing rate at 1.342642 US$: GBP, quarterly average rate at 1.3784972 US$: GBP and yearly average rate at 1.3853499 US$: GBP, for the three and nine months ended September 30, 2020, closing rate at 1.2923 US$: GBP, quarterly average rate at 1.293173 US$: GBP and yearly average rate of 1.271713. For the year ended December 31, 2020 closing rate at 1.260983 US$: GBP, average rate at 1.260983 US$: GBP.

 

Revenue Recognition and Unearned Revenue

 

The Company recognizes revenue from satellite services when earned, as services are rendered or delivered to customers. Equipment sales revenue is recognized when the equipment is delivered to and accepted by the customer. Only equipment sales are subject to warranty. Historically, the Company has not incurred significant expenses for warranties. Equipment sales which have been prepaid, before the goods are shipped are recorded as contract liabilities and once shipped is recognized as revenue. The Company also records as contract liabilities, certain annual plans for airtime, which are paid in advance. Once airtime services are incurred, they are recognized as revenue. Unbilled revenue is recognized for airtime plans whereby the customer is invoiced for its data usage the following month after services are incurred.

 

The Company’s customers generally purchase a combination of our products and services as part of a multiple element arrangement. The Company’s assessment of which revenue recognition guidance is appropriate to account for each element in an arrangement can involve significant judgment. This assessment has a significant impact on the amount and timing of revenue recognition.

 

9
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The Company recognizes revenue when its customer obtains control of promised goods or services, in an amount that reflects the consideration which we expect to receive in exchange for those goods or services. To determine revenue recognition for arrangements that the Company determines are within the scope of ASC 606, we perform the following five steps: (i) identify the contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenue when (or as) we satisfy a performance obligation. The five-step model is applied to contracts when it is probable that we will collect the consideration we are entitled to in exchange for the goods or services transferred to the customer. At contract inception, once the contract is determined to be within the scope of ASC 606, we assess the goods or services promised within each contract and determine those that are performance obligations and assess whether each promised good or service is distinct. We then recognize revenue in the amount of the transaction price that is allocated to the respective performance obligation when (or as) the performance obligation is satisfied.

 

In accordance with ASU No. 2016-12, Revenue from Contracts with Customers (Topic 606): Narrow-Scope Improvements and Practical Expedient, which is to (1) clarify the objective of the collectability criterion for applying paragraph 606-10-25-7; (2) permit an entity to exclude amounts collected from customers for all sales (and other similar) taxes from the transaction price; (3) specify that the measurement date for noncash consideration is contract inception; (4) provide a practical expedient that permits an entity to reflect the aggregate effect of all modifications that occur before the beginning of the earliest period presented when identifying the satisfied and unsatisfied performance obligations, determining the transaction price, and allocating the transaction price to the satisfied and unsatisfied performance obligations; (5) clarify that a completed contract for purposes of transition is a contract for which all (or substantially all) of the revenue was recognized under legacy GAAP before the date of initial application, and (6) clarify that an entity that retrospectively applies the guidance in Topic 606 to each prior reporting period is not required to disclose the effect of the accounting change for the period of adoption. The amendments of this ASU are effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. There was no impact as a result of adopting this ASU on the financial statements and related disclosures. Based on the terms and conditions of the product arrangements, the Company believes that its products and services can be accounted for separately as its products and services have value to the Company’s customers on a stand-alone basis. When a transaction involves more than one product or service, revenue is allocated to each deliverable based on its relative fair value; otherwise, revenue is recognized as products are delivered or as services are provided over the term of the customer contract.

 

Contract liabilities is shown separately in the unaudited consolidated balance sheets as current liabilities. At September 30, 2021 and December 31, 2020, we had contract liabilities of $40,956 and $36,704, respectively.

 

Cost of Product Sales and Services

 

Cost of sales consists primarily of materials, airtime and overhead costs incurred internally and amounts incurred to contract manufacturers to produce our products, airtime and other implementation costs incurred to install our products and train customer personnel, and customer service and third-party original equipment manufacturer costs to provide continuing support to our customers. There are certain costs which are deferred and recorded as prepaids, until such revenue is recognized. Refer to revenue recognition above as to what constitutes deferred revenue.

 

Shipping and handling costs are included as a component of costs of product sales in the Company’s consolidated statements of operations because the Company includes in revenue the related costs that the Company bills its customers.

 

Intangible assets

 

Intangible assets include customer contracts purchased and recorded based on the cost to acquire them. These assets are amortized over 10 years. Useful lives of intangible assets are periodically evaluated for reasonableness and the assets are tested for impairment whenever events or changes in circumstances indicate that the carrying amount may no longer be recoverable.

 

Goodwill and other intangible assets

 

In accordance with ASC 350-30-65, “Intangibles - Goodwill and Others”, the Company assesses the impairment of identifiable intangibles whenever events or changes in circumstances indicate that the carrying value may not be recoverable.

 

Factors the Company considers to be important which could trigger an impairment review include the following:

 

  Significant underperformance relative to expected historical or projected future operating results;
  Significant changes in the manner of use of the acquired assets or the strategy for the overall business; and
  Significant negative industry or economic trends.

 

When the Company determines that the carrying value of intangibles may not be recoverable based upon the existence of one or more of the above indicators of impairment and the carrying value of the asset cannot be recovered from projected undiscounted cash flows, the Company records an impairment charge. The Company measures any impairment based on a projected discounted cash flow method using a discount rate determined by management to be commensurate with the risk inherent in the current business model. Significant management judgment is required in determining whether an indicator of impairment exists and in projecting cash flows. The Company recorded an impairment charge of $0 and $0, during the nine months ended September 30, 2021 and for the year ended December 31, 2020, respectively.

 

10
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Property and Equipment

 

Property and equipment are carried at historical cost less accumulated depreciation. Depreciation is based on the estimated service lives of the depreciable assets and is calculated using the straight-line method. Expenditures that increase the value or productive capacity of assets are capitalized. Fully depreciated assets are retained in the property and equipment, and accumulated depreciation accounts until they are removed from service. When property and equipment are retired, sold or otherwise disposed of, the asset’s carrying amount and related accumulated depreciation are removed from the accounts and any gain or loss is included in operations. Repairs and maintenance are expensed as incurred.

 

The estimated useful lives of property and equipment are generally as follows:

 

   Years
Office furniture and fixtures  4
Computer equipment  4
Rental equipment  4
Appliques  10
Website development  2

 

Depreciation expense for the three months ended September 30, 2021 and 2020 were $72,206 and $67,447, respectively. Depreciation expense for the nine months ended September 30, 2021 and 2020 were $206,654 and $199,242, respectively.

 

Impairment of long-lived assets

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable, or at least annually. The Company recognizes an impairment loss when the sum of expected undiscounted future cash flows is less than the carrying amount of the asset. The amount of impairment is measured as the difference between the asset’s estimated fair value and its book value. The Company did not consider it necessary to record any impairment charges during the periods ended September 30, 2021 and September 30, 2020, respectively.

 

Accounting for Derivative Instruments

 

Derivatives are required to be recorded on the balance sheet at fair value. These derivatives, including embedded derivatives in the Company’s structured borrowings, are separately valued and accounted for on the Company’s balance sheet. Fair values for exchange traded securities and derivatives are based on quoted market prices. Where market prices are not readily available, fair values are determined using market-based pricing models incorporating readily observable market data and requiring judgment and estimates.

 

The Company did not identify any assets or liabilities that are required to be presented on the consolidated balance sheets at fair value in accordance with the accounting guidance. The carrying amounts reported in the balance sheet for cash, accounts payable, and accrued expenses approximate their estimated fair market value based on the short-term maturity of the instruments.

 

11
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Stock Based Compensation

 

Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the consolidated financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award.

 

Pursuant to ASC Topic 718, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the vesting period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date. Further, ASC Topic 718, provides guidance about which changes to the terms or conditions of a share-based payment award require an entity to apply modification accounting in Topic 718, such as the repricing of share options, which would revalue those options and the accounting for the cancellation of an equity award whether a replacement award or other valuable consideration is issued in conjunction with the cancellation. If not, the cancellation is viewed as a replacement and not a modification, with a repurchase price of $0.

 

Income Taxes

 

The Company accounts for income taxes pursuant to the provision of ASC 740-10, “Accounting for Income Taxes” (“ASC 740-10”) which requires, among other things, an asset and liability approach to calculating deferred income taxes. The asset and liability approach require the recognition of deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax bases of assets and liabilities. A valuation allowance is provided to offset any net deferred tax assets for which management believes it is more likely than not that the net deferred asset will not be realized.

 

The Company follows the provision of ASC 740-10 related to Accounting for Uncertain Income Tax Positions. When tax returns are filed, there may be uncertainty about the merits of positions taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions.

 

Tax positions that meet the more likely than not recognition threshold is measured at the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefit associated with tax positions taken that exceed the amount measured as described above should be reflected as a liability for uncertain tax benefits in the accompanying balance sheet along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

The Company believes its tax positions are all more likely than not to be upheld upon examination. As such, the Company has not recorded a liability for uncertain tax benefits.

 

The Company has adopted ASC 740-10-25, “Definition of Settlement,” which provides guidance on how an entity should determine whether a tax position is effectively settled for the purpose of recognizing previously unrecognized tax benefits and provides that a tax position can be effectively settled upon the completion and examination by a taxing authority without being legally extinguished. For tax positions considered effectively settled, an entity would recognize the full amount of tax benefit, even if the tax position is not considered more likely than not to be sustained based solely on the basis of its technical merits and the statute of limitations remains open. The federal and state income tax returns of the Company are subject to examination by the IRS and state taxing authorities, generally for three years after they are filed.

 

Leases

 

Effective January 1, 2019, the Company accounts for its leases under ASC 842, Leases. Under this guidance, arrangements meeting the definition of a lease are classified as operating or financing leases, and are recorded on the consolidated balance sheet as both a right of use asset and lease liability, calculated by discounting fixed lease payments over the lease term at the rate implicit in the lease or the Company’s incremental borrowing rate. Lease liabilities are increased by interest and reduced by payments each period, and the right of use asset is amortized over the lease term. For operating leases, interest on the lease liability and the amortization of the right of use asset result in straight-line rent expense over the lease term. For finance leases, interest on the lease liability and the amortization of the right of use asset results in front-loaded expense over the lease term. Variable lease expenses are recorded when incurred.

 

In calculating the right of use asset and lease liability, the Company has elected to combine lease and non-lease components. The Company excludes short-term leases having initial terms of 12 months or less from the new guidance as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term.

 

The Company continues to account for leases in the prior period financial statements under ASC Topic 840.

 

12
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Research and Development

 

The Company accounts for research and development costs in accordance with the Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. For the nine months ended September 30, 2021 and 2020, there were no expenditures on research and development.

 

Earnings per Common Share

 

Net income (loss) per common share is calculated in accordance with ASC Topic 260: Earnings per Share (“ASC 260”). Basic income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. The computation of diluted net loss per share does not include dilutive common stock equivalents in the weighted average shares outstanding as they would be anti-dilutive. In periods where the Company has a net loss, all dilutive securities are excluded.

 

The following are dilutive common stock equivalents during the nine months ended:

 

   September 30, 2021   September 30, 2020 
         
Convertible notes payable (1)   -    1,152,411 
Stock Options   854,892    7,809 
Stock Warrants   2,530,092    800 
Total   3,384,984    1,161,020 

 

(1) There were 0 and 1,152,411 shares of our common stock issuable upon conversion of $1,152,411 of Convertible Notes Payable at a conversion rate of $1.00 per share, as of September 30, 2021 and 2020, not accounting for 9.99% beneficial ownership limitation.

 

Related Party Transactions

 

A party is considered to be related to the Company if the party directly or indirectly or through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. A party which can significantly influence the management or operating policies of the transacting parties or if it has an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests is also a related party, (see Note 13).

 

13
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Recent Accounting Pronouncements

 

In November 2018, the FASB amended Topic 842, Leases, by issuing ASU No. 2016-02, which requires lessees to recognize leases on-balance sheet and disclose key information about leasing arrangements. Topic 842 with ASU No. 2018-01, Land Easement Practical Expedient for Transition to Topic 842; ASU No. 2018-10, Codification Improvements to Topic 842, Leases; and ASU No. 2018-11, Targeted Improvements. The new standard establishes a right-of-use model (ROU) that requires a lessee to recognize a ROU asset and lease liability on the balance sheet for all leases with a term longer than 12 months. Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the income statement. The new standard was effective for us on January 1, 2019, however the Company did not have any leases that met the criteria as established above, until July 24, 2019, when the Company entered into a three-year lease for its UK office and warehouse for annual rent of £25,536 or GBP: USD using exchange rate close for the nine months ended September 30, 2021, for liability of 1.3426420 or $34,286. An entity may choose to use either (1) its effective date or (2) the beginning of the earliest comparative period presented in the financial statements as its date of initial application. If an entity chooses the second option, the transition requirements for existing leases also apply to leases entered into between the date of initial application and the effective date. The entity must also recast its comparative period financial statements and provide the disclosures required by the new standard for the comparative periods. Consequently, financial information will not be updated, and the disclosures required under the new standard will not be provided for dates and periods before January 1, 2019.

 

At September 30, 2021, the Company had current and long-term operating lease liabilities of $27,801 and $0, respectively, and right of use assets of $30,658.

 

Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the consolidated financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures.

 

14
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 2 - INVENTORIES

 

At September 30, 2021 and December 31, 2020, inventories consisted of the following:

 

   September 30, 2021   December 31, 2020 
Finished goods  $982,909   $361,422 
Less reserve for obsolete inventory   -    - 
Total  $982,909   $361,422 

 

For the nine months ended September 30, 2021 and the year ended December 31, 2020, the Company did not make any change for reserve for obsolete inventory.

 

NOTE 3 – VAT RECEIVABLE

 

On January 1, 2021, VAT rules relating to imports and exports between the UK and EU changed as a result, of the UK’s departure from the EU, (“BREXIT”). For the nine months ending September 30, 2021, the Company recorded a receivable in the amount of $446,657 for amounts available to reclaim against the tax liability from UK and EU countries. Subsequently to September 30, 2021, the Company has received a total of $174,402, in regard to this receivable.

 

NOTE 4 – PREPAID EXPENSES

 

Prepaid expenses amounted to $8,653 at September 30, 2021 and $1,784 at December 31, 2020. Prepaid expense includes prepaid rent of $6,169, as well as cost associated with certain contract liabilities. The current portion consists of costs paid for future services which will occur within a year.

 

NOTE 5 - PROPERTY AND EQUIPMENT

 

At September 30, 2021 and December 31, 2020, property and equipment, net of fully depreciated assets, consisted of the following:

  

   September 30, 2021   December 31, 2020 
Office furniture and fixtures  $15,633   $6,470 
Computer equipment   59,162    33,361 
Rental equipment   47,345    48,187 
Appliques   2,160,096    2,160,096 
Website development   128,427    69,149 
Property, Plant and Equipment, Gross   2,410,663    2,317,263 
Less accumulated depreciation   (1,415,506)   (1,211,099)
           
Total  $995,157   $1,106,164 

 

Depreciation expense for the three months ended September 30, 2021 and 2020 were $72,206 and $67,447, respectively. Depreciation expense for the nine months ended September 30, 2021 and 2020 were $206,654 and $199,242, respectively.

 

NOTE 6 – INTANGIBLE ASSETS

 

On December 10, 2014, the Company entered the satellite voice and data equipment sales and service business through the purchase of certain contracts from Global Telesat Corp. (“Global Telesat”). These contracts permit the Company to utilize the Globalstar, Inc. and Globalstar LLC (collectively, “Globalstar”) mobile satellite voice and data network. The purchase price for the contracts of $250,000 was paid by the Company under an asset purchase agreement by and among the Company, its wholly owned subsidiary, Orbital Satcom, Global Telesat and World Surveillance Group, Inc.

 

15
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Included in the purchased assets are: (i) the rights and benefits granted to Global Telesat under each of the Globalstar Contracts, subject to certain exclusions, (ii) account and online access to the Globalstar Cody Simplex activation system, (iii) Global Telesat’s existing customers who are serviced pursuant to the Globalstar Contracts (only as to their business directly and exclusively related to the Globalstar Contracts), and (iv) all of Global Telesat’s rights and benefits directly and exclusively related to the Globalstar Contracts.

 

Amortization of customer contracts are included in depreciation and amortization. For the nine months ended September 30, 2021 and 2020, the Company amortized $18,750, respectively. Future amortization of intangible assets is as follows:

 

      
2021  $6,250 
2022   25,000 
2023   25,000 
2024   25,000 
Total  $81,250 

 

For the nine months ended September 30, 2021 and 2020, there were no additional expenditures on research and development.

 

NOTE 7 - ACCOUNTS PAYABLE AND ACCRUED OTHER LIABILITIES

 

Accounts payable and accrued other liabilities consisted of the following:

 

   September 30, 2021   December 31, 2020 
Accounts payable  $721,294   $747,476 
Rental deposits   11,580    10,761 
Customer deposits payable   57,142    53,570 
VAT liability & sales tax payable   16,971    50,453 
Pre-merger accrued other liabilities   65,948    65,948 
Accrued interest   138    99,982 
Accrued other liabilities   10,973    24,413 
Total  $884,046   $1,052,603 

 

NOTE 8 – LINE OF CREDIT

 

On October 9, 2019, Orbital Satcom Corp, entered into a short-term loan agreement for $29,000, with Amazon Capital Services Inc. The one-year term loan is paid monthly, has an interest rate of 9.72%, with late payment penalty interest of 11.72%. For the nine months ended September 30, 2021 and 2020, the Company recorded interest expense of $0 and $725, respectively. The short-term line of credit balance as of September 30, 2021 and December 31, 2020, was $0 and $0.

 

16
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 9 – NOTE EXCHANGE AGREEMENT

 

On April 30, 2019, the Company entered into a Shares for Note Exchange Agreement (each, an “Agreement” and collectively, the “Agreements”) with certain holders of the Company’s preferred stock (the “Converting Stockholders”). Pursuant to the terms of the Agreements, the Company agreed to exchange the preferred shares held by the respective Converting Stockholders for promissory notes as follows:

 

Series of

Preferred

Stock

 

No. of

Converting

Holders of

Preferred

Stock

 

Aggregate

No. of

Shares Held

by

Converting

Stockholders

  

Aggregate

Principal

Amount of

Notes into

which

Shares

Converted

 
B  1   222   $11 
C  1   123,526   $12,353 
D  3   147,577   $29,516 
F  1   23,333   $233 
G  2   346,840   $3,468 
H  3   916   $916 
I  3   3,241   $3,241 
J  5   4,296   $42,961 
K  7   70,571   $70,571 
L  3   1,333   $5,000 
   TOTAL:   721,855   $168,270 

 

In exchange for the above-referenced shares of preferred stock, the Company issued a promissory note (each, a “Note” and collectively, the “Notes”) to each of the Converting Stockholders on April 30, 2019. Each Note bears interest at a rate of 6% per annum and is due on the second anniversary of the issuance date. Interest accrues on a simple interest, non-compounded basis and will be added to the principal amount on the maturity date. In the event that any amount due under a Note is not paid as and when due, such amounts will accrue interest at the rate of 12% per year, simple interest, non-compounding, until paid. The Company may prepay the Notes at any time.

 

During the periods ended September 30, 2021 and December 31, 2020, the Company repaid $121,848 and $0 of the notes, leaving a balance of $0 and $121,848, respectively as short-term notes payable. For the nine months ended September 30, 2021, the Company recorded interest in relation to the note of $2,503.

 

17
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 10 – CONVERTIBLE NOTES PAYABLE

 

Convertible notes payable – long term

 

March 2021 Financing

 

On March 5, 2021, the Company entered into a Note Purchase Agreement (the “March 2021 NPA”) by and between the Company and one individual accredited investor (the “Lender”). Pursuant to the terms of the March 2021 NPA, the Company sold a convertible promissory note with a principal amount of $350,000 (the “March 2021 Note”). The March 2021 Note is a general, unsecured obligation of the Company and bears simple interest at a rate of 7% per annum, and matures on the third anniversary of the date of issuance (the “Maturity Date”), to the extent that the March 2021 Note and the principal amount and any interest accrued thereunder have not been converted into shares of the Company’s common stock. In the event that any amount due under the March 2021 Note is not paid as and when due, such amount will accrue interest at the rate of 12% per year, simple interest, non-compounding, until paid. The Company may not pre-pay or redeem the March 2021 Note other than as required by the Agreement. The Noteholder have an optional right of conversion such that a Noteholder may elect to convert his March 2021 Note, in whole or in part, outstanding as of such time, into the number of fully paid and non-assessable shares of the Company’s common stock as determined by dividing the indebtedness under the March 2021 Note price equal to the lesser of (a) $7.50 per share, and (b) a 30% discount to the price of the common stock in the qualified transaction. Following an event of default, the conversion price shall be adjusted to be equal to the lower of: (i) the then applicable conversion price or (ii) the price per share of 85% of the lowest traded price for the Company’s common stock during the 15 trading days preceding the relevant conversion. In addition, subject to the ownership limitations, if a qualified transaction is completed, without further action from the Noteholder, on the closing date of the qualified transaction, 50% of the principal amount of this March 2021 Note and all accrued and unpaid interest shall be converted into Company common stock at a conversion price equal to the 30% discount to the offering price in such qualified transaction, which price shall be proportionately adjusted for stock splits, stock dividends or similar events. A “Qualified Transaction” refers the completion of the public offering of the Company’s securities stock with gross proceeds of at least $10,000,000 pursuant to which the Company’s securities become registered pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended, or a merger with a company listed on the Nasdaq or Canadian stock exchanges, as amended. The Noteholder is granted registration rights and pre-emptive rights. In addition, the March 2021 NPA includes customary events of default, including, among others: (i) non-payment of amounts due thereunder, (ii) non-compliance with covenants thereunder, (iii) bankruptcy or insolvency. The Company’s issuance of the March 2021 Note under the terms of the March 2021 NPA was made pursuant to an exemption from registration under the Securities Act of 1933, as amended (the “Securities Act”) in reliance on Section 4(a)(2) of the Securities Act as a transaction by an issuer not involving a public offering. The investor in the March 2021 Note is an “accredited investor” as such term is defined in Rule 501(a) of Regulation D under the Securities Act. There were no discounts or brokerage fees associated with this offering. The Company used the offering proceeds for working capital and general corporate purposes.

 

The balances of the Company’s convertible notes payable consist of the following:

 

   September 30,
2021
   December 31, 2020 
May 2019 Notes  $    -   $462,085 
August 2020 Notes   -    588,182 
December 2020 Notes   -    244,000 
March 2021 Notes   -    - 
    -    1,294,267 
Debt Discount   -    (1,084,944)
    -      
Total  $-   $209,323 

 

For the nine months ended September 30, 2021 and 2020, we amortized the discount on the debt, to interest expense of $1,425,365 and $752,130.

 

For the nine months ended September 30, 2021, the Holders converted a total of $1,644,267 of the convertible debt to 1,345,468 shares of common shares.

 

On June 15, 2020, the change in conversion price from $0.50 to $1.00 per share, resulted in a difference in the carrying value of the balance of the note payable. Under ASC 470-50-40-13, if it is determined that the original and new debt instruments are substantially different, the new debt instrument shall be initially recorded at fair value, and that amount shall be used to determine the debt extinguishment gain or loss to be recognized and the effective rate of the new instrument. The original debt had a carrying value of $269,262 as of June 15, 2020, the fair value of the amended debt was $0 ($792,932 principle netted with the $792,392 note payable discount), which resulted a gain from the extinguishment of debt $269,262. Further, as of June 30, 2020, the Company recorded a beneficial conversion feature of the amended note of $17,041, resulting in a balance of unamortized discount notes payable of $775,892 as of June 30, 2020. For the three months ended September 30, 2020, the Company amortized discount on the debt, to interest expense of $348,563, resulting in a balance of unamortized discount notes payable of $427,329.

 

For the nine months ended September 30, 2020, the Holders converted $585,589 of the convertible debt to common stock, resulting in an issuance of 597,657 common shares, 24,135 common shares at the conversion rate of $0.50 per share and 573,522 common shares at the conversion rate of $1.00 per share. The balance of the convertible notes at September 30, 2020, net of unamortized discount of $1,051,382, is $101,029.

 

18
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 11 CORONA VIRUS LOANS

 

On April 20, 2020, the Board, approved for its wholly owned UK subsidiary, Global Telesat Communications Limited (“GTC”), to apply for a Coronavirus Interruption Loan, offered by the UK government, for an amount up to £250,000. On July 16, 2020 (the “Issue Date”), GTC, entered into a Coronavirus Interruption Loan Agreement (the “Debenture”) by and among the Company and HSBC UK Bank PLC (the “Lender”) for an amount of £250,000, or $345,700 at an exchange rate of GBP:USD of 1.3828. The Debenture bears interest beginning July 16, 2021, at a rate of 3.99% per annum over the Bank of England Base Rate (0.1% as of July 16, 2020), payable monthly on the outstanding principal amount of the Debenture. The Debenture has a term of 6 years from the date of drawdown, July 15, 2026, the “Maturity Date”. The first repayment of £4,167 (exclusive of interest) will be made 13 month(s) after July 16, 2020. Voluntary prepayments are allowed with 5 business days’ written notice and the amount of the prepayment is equal to 10% or more of the limit or, if less, the balance of the debenture. The Debenture is secured by all GTC’s assets as well as a guarantee by the UK government, with the proceeds of the Debenture are to be used for general corporate and working capital purposes. The Debenture includes customary events of default, including, among others: (i) non-payment of amounts due thereunder, (ii) non-compliance with covenants thereunder, (iii) bankruptcy or insolvency (each, an “Event of Default”). Upon the occurrence of an Event of Default, the Debenture becomes payable upon demand. As of September 30, 2021, the Company has recorded $55,943 as current portion of notes payable and $268,528 as notes payable long term.

 

On May 8, 2020, Orbsat Corp was approved for the US funded Payroll Protection Program, (“PPP”) loan. The loan is for $20,832 and has a term of 2 years, of which the first 6 months are deferred at an interest rate of 1%. On May 23, 2021, BlueVine, the Company’s SBA approved mortgage lender and originator, notified the Company, that the loan in the amount of $20,832, has been forgiven. As of September 30, 2021, the Company has recorded $20,832 as gain on forgiveness of debt.

 

NOTE 12 - STOCKHOLDERS’ EQUITY

 

Capital Structure

 

On March 28, 2014, in connection with the Reincorporation (see Note 1), all share and per share values for all periods presented in the accompanying condensed consolidated financial statements are retroactively restated for the effect of the Reincorporation.

 

On March 5, 2016, the Company shareholders voted in favor of an amendment to its Articles of Incorporation to increase the total number of shares of authorized capital stock to 800,000,000 shares consisting of (i) 750,000,000 shares of common stock and (ii) 50,000,000 shares of preferred stock from 220,000,000 shares consisting of (i) 200,000,000 shares of common stock and (ii) 20,000,000 shares of preferred stock.

 

Effective March 8, 2018, we conducted a reverse split of our common stock at a ratio of 1 for 150. All share and per share information in the accompanying condensed consolidated financial statements and footnotes has been retroactively restated to reflect the reverse split.

 

On July 24, 2019, the Company filed a Certificate of Change (the “Certificate of Change”) with the Nevada Secretary of State. The Certificate of Change provides for (i) a 1-for-15 reverse split of the Company’s common stock, $0.0001 par value per share, and the Company’s preferred stock, $0.0001 par value per share, (ii) a reduction in the number of authorized shares of common stock in direct proportion to the reverse split (i.e. from 750,000,000 shares to 50,000,000 shares), and (iii) a reduction in the number of authorized shares of preferred stock in direct proportion to the reverse split (i.e. from 50,000,000 shares to 3,333,333 shares). No fractional shares will be issued in connection with the reverse split. Stockholders who otherwise would be entitled to receive fractional shares of common stock or preferred stock, as the case may be, will have the number of post-reverse split shares to which they are entitled rounded up to the nearest whole number of shares. No stockholders will receive cash in lieu of fractional shares. The reverse split was approved by FINRA on August 19, 2019.

 

On May 28, 2021, the Company effected a reverse stock split of its common stock at a ratio of 1-for-5. No fractional shares of common stock were issued as a result of the reverse split. Stockholders of record who were otherwise entitled to receive a fractional share received a whole share. The conversion or exercise prices of Company’s issued and outstanding convertible securities, stock options and warrants will be adjusted accordingly. All information presented in this Quarterly Report on Form 10-Q, other than in Company’s consolidated financial statements and the notes thereto assumes a 1-for-5 reverse stock split of Company’s outstanding shares of common stock, and unless otherwise indicated, all such amounts and corresponding conversion price or exercise price data set forth in this Quarterly Report on Form 10-Q have been adjusted to give effect to such assumed reverse stock split.

 

Listing on the Nasdaq Capital Market

 

On May 28, 2021, our common stock and Warrants commenced trading on Nasdaq under the symbols “OSAT” and “OSATW,” respectively.

 

19
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

As of September 30, 2021, the authorized capital of the Company consists of 50,000,000 shares of common stock, par value $0.0001 per share, 3,333,333 shares of preferred stock, par value $0.0001 per share.

 

Preferred Stock

 

As of September 30, 2021, there were 3,333,333 shares of Preferred Stock authorized, none of which are issued and outstanding.

 

Warrants

 

As of September 30, 2021, there were 2,386,092 registered warrants authorized to purchase of common stock issued and outstanding.

 

On June 2, 2021, the Company issued 2,880,000 warrants to purchase 2,880,000 shares of common stock in an offering, at an exercise price of $5.00 and a term of 5 years.

 

On June 10, 2021, the Company issued 1,000 shares of common stock in our June Offering, as described below, for the exercise of 1,000 warrants, at an exercise price of $5.00, for cash consideration of $5,000.

 

On June 28, 2021, the Company issued an additional 432,000 warrants to purchase 432,000 shares of common stock in June Offering, at an exercise price of $5.00 and a term of 5 years.

 

On July 6, 2021, the Company issued 78,500 shares of common stock, for the exercise of 78,500 warrants, at an exercise price of $5.00, for cash consideration of $392,500.

 

On July 8, 2021, the Company issued 425,000 shares of common stock, for the exercise of 425,000 warrants, at an exercise price of $5.00, for cash consideration of $2,125,000.

 

On July 12, 2021, the Company issued 2,000 shares of common stock, for the exercise of 2,000 warrants, at an exercise price of $5.00, for cash consideration of $10,000.

 

On July 13, 2021, the Company issued 59,853 shares of common stock, for the exercise of 59,853 warrants, at an exercise price of $5.00, for cash consideration of $299,265.

 

On July 14, 2021, the Company issued 278,555 shares of common stock, for the exercise of 278,555 warrants, at an exercise price of $5.00, for cash consideration of $1,392,775.

 

On July 19, 2021, the Company issued 1,000 shares of common stock, for the exercise of 1,000 warrants, at an exercise price of $5.00, for cash consideration of $5,000.

 

On July 30, 2021, the Company issued 80,000 shares of common stock, for the exercise of 80,000 warrants, at an exercise price of $5.00, for cash consideration of $400,000.

 

Underwriter Warrants

 

In addition to, but separate from, the registered warrants included in the units sold in the June Offering, the Company issued 144,000 warrants to Maxim Group LLC, the underwriter (the “Underwriter Warrants”) in connection with the June Offering. The Underwriter Warrants expire five years from the effective date of the June Offering and are exercisable at a per share price equal to $5.50 per share, or 110% of the public offering price per unit in the June Offering.

 

As of September 30, 2021, there were 144,000 Underwriter Warrants issued and outstanding.

 

A summary of the status of the Company’s total outstanding warrants and changes during the nine months ended September 30, 2021 is as follows:

  

Number of

Warrants

  

Weighted

Average Exercise

Price

  

Weighted

Average

Remaining

Contractual

Life

(Years)

 
Balance at January 1, 2021   800   $300.00    0.37 
Granted   3,456,000    -    - 
Exercised   (925,908)   -    - 
Forfeited   -    -    - 
Cancelled   (800)   -    - 
Balance outstanding and exercisable at September 30, 2021   2,530,092   $5.03    4.67 

 

As of September 30, 2021, and December 31, 2020, there were 2,530,092 and 800 warrants outstanding, respectively.

 

20
 

 

Common Stock

 

As of September 30, 2021, there were 50,000,000 shares of common stock authorized and 6,469,263 shares issued and outstanding.

 

On February 19, 2021, the Board of Directors of the Company unanimously adopted an amendment to the Company’s Articles of Incorporation to effect a reverse stock split at a ratio of (i) no less than 1-for-2 shares of Common Stock, and (ii) no more than 1-for-5 shares of Common Stock, the exact ratio to be determined in the sole discretion of the Board of Directors, at any time before August 31, 2021. The Board of Directors has obtained (by written consent) the approval of the Company’s stockholders who, in the aggregate, own 2,686,337 shares of Common Stock, or 63.5% of the outstanding shares of Common Stock of the Company prior to the reverse split action.

 

On January 12, 2021, the Company issued an aggregate of 30,000 shares of common stock upon the conversion of $30,000 of its convertible debt, at the conversion rate of $1.00 per share.

 

On February 23, 2021, the Company issued an aggregate of 80,289 shares of common stock upon the conversion of $80,289 of its convertible debt, at the conversion rate of $1.00 per share.

 

On February 23, 2021, the Company issued an aggregate of 120,000 shares of common stock upon the conversion of $150,000 of its convertible debt, at the conversion rate of $1.25 per share.

 

On February 23, 2021, the Company issued an aggregate of 1,000 shares of common stock for services in the amount of $14,200.

 

On March 1, 2021, the Company issued an aggregate of 149,532 shares of common stock upon the conversion of $149,532 of its convertible debt, at the conversion rate of $1.00 per share.

 

On March 1, 2021, the Company issued an aggregate of 38,616 shares of common stock upon the conversion of $48,270 of its convertible debt, at the conversion rate of $1.25 per share.

 

On March 24, 2021, the Company’s shareholders via majority shareholder consent authorized a stock split not to exceed 1 for 5 reverse stock split. A definitive Information Statement relating to the shareholder consent was filed with the SEC on March 13, 2021. The Company’s Board of Directors subsequently approved a 1-for-5 reverse stock split. The Company has filed a Certificate of Change to its Amended and Restated Articles of Incorporation to effect a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-5. The effective time of the reverse stock split will be 12:01 a.m. ET on May 28, 2021. The Company’s common stock will begin trading on a split-adjusted basis commencing upon market open on May 28, 2021. The common stock will be assigned a new CUSIP number, 68557F 209. The warrants will be assigned the CUSIP number, 68557F 118. No fractional shares of common stock will be issued as a result of the reverse stock split. Stockholders of record who would otherwise be entitled to receive a fractional share will receive a whole share.

 

On May 20, 2021, Company issued an aggregate of 29,800 shares of common stock upon the conversion of $29,800 of its convertible debt, at a weighted average conversion rate of $1.00.

 

On May 27, 2021, Company issued an aggregate of 897,231 shares of common stock upon the conversion of $1,156,377 of its convertible debt, at a weighted average conversion rate of $1.29.

 

On May 28, 2021, Company entered into an Underwriting Agreement (the “Underwriting Agreement”) with Maxim Group LLC (the “Underwriter”), pursuant to which the Company agreed to issue and sell to the Underwriter in an underwritten public offering 2,880,000 units consisting of one share of common stock and one warrant, exercisable for one share of common stock at a public offering price of $5.00 per unit, (after giving effect to a 1-for-5 reverse stock split, discussed above) for aggregate gross proceeds of approximately $14,400,000 before deducting underwriting discounts, commissions, and other offering expenses (the “June Offering”). The common stock and warrants were immediately separable and were issued separately. The common stock and warrants began trading on the Nasdaq Capital Market, on May 28, 2021, under the symbols “OSAT” and “OSATW,” respectively. In addition, the Company In addition, the Company has granted the Underwriter a 45-day option to purchase an additional 432,000 shares of common stock and/or warrants to purchase up to an aggregate of 432,000 shares of common stock, in any combination thereof, at the public offering price per security, less the underwriting discounts and commissions, to cover over-allotments, if any. The June Offering closed on June 2, 2021.In connection with closing of the June Offering, the Underwriter partially exercised its overallotment option and purchased an additional 432,000 warrants at $0.01 per warrant for additional gross proceeds to the Company of $4,320. On June 28, 2021, the Underwriter, upon the exercise in full of the balance of its over-allotment option, purchased 432,000 additional shares of the common stock for additional gross proceeds to the Company of $2,155,680.

 

We have issued to the Underwriter warrants to purchase up to a total of 144,000 shares of common stock (5% of the shares of common stock included in the Units, excluding the over-allotment, if any) (the “Underwriter Warrants”). The Underwriter Warrants are exercisable at any time, and from time to time, in whole or in part, during the period commencing 180 days from the effective date of the registration statement, and expire five years from the effective date of the offering, which period is in compliance with FINRA Rule 5110(e). The Underwriter Warrants are exercisable at a per share price equal to $5.50 per share, or 110% of the public offering price per unit in the offering. The Underwriter Warrants have been deemed compensation by FINRA and are therefore subject to a 180-day lock-up pursuant to Rule 5110(e)(1) of FINRA. The underwriter (or permitted assignees under Rule 5110(e)(2)) will not sell, transfer, assign, pledge, or hypothecate these warrants or the securities underlying these warrants, nor will they engage in any hedging, short sale, derivative, put, or call transaction that would result in the effective economic disposition of the warrants or the underlying securities for a period of 180 days from the effective date of the registration statement. In addition, the warrants provide for certain piggyback registration rights. The piggyback registration rights provided will not be greater than five years from the effective date of the registration statement in compliance with FINRA Rule 5110(g)(8). We will bear all fees and expenses attendant to registering the securities issuable on exercise of the Underwriter Warrants. The exercise price and number of shares issuable upon exercise of the Underwriter Warrants may be adjusted in certain circumstances including in the event of a stock dividend, extraordinary cash dividend or our recapitalization, reorganization, merger or consolidation. However, the warrant exercise price or underlying shares will not be adjusted for issuances of shares of common stock at a price below the warrant exercise price.

 

On June 10, 2021, the Company issued 1,000 shares of common stock, for the exercise of 1,000 warrants, at an exercise price of $5.00, for cash consideration of $5,000.

 

On July 6, 2021, the Company issued 78,500 shares of common stock, for the exercise of 78,500 warrants, at an exercise price of $5.00, for cash consideration of $392,500.

 

On July 8, 2021, the Company issued 425,000 shares of common stock, for the exercise of 425,000 warrants, at an exercise price of $5.00, for cash consideration of $2,125,000.

 

On July 12, 2021, the Company issued 2,000 shares of common stock, for the exercise of 2,000 warrants, at an exercise price of $5.00, for cash consideration of $10,000.

 

On July 13, 2021, the Company issued 59,853 shares of common stock, for the exercise of 59,853 warrants, at an exercise price of $5.00, for cash consideration of $299,265.

 

On July 14, 2021, the Company issued 278,555 shares of common stock, for the exercise of 278,555 warrants, at an exercise price of $5.00, for cash consideration of $1,392,775.

 

On July 15, 2021, the Company issued 5,000 shares of common stock in connection with the exercise of 5,000 options, for cash consideration of $5,000.

 

On July 19, 2021, the Company issued 1,000 shares of common stock, for the exercise of 1,000 warrants, at an exercise price of $5.00, for cash consideration of $5,000.

 

On July 30, 2021, the Company issued 80,000 shares of common stock, for the exercise of 80,000 warrants, at an exercise price of $5.00, for cash consideration of $400,000.

 

On September 3, 2021, the Company issued 10,000 shares of common stock in connection with restricted stock awards, with a fair market value of $5.35 per share, from the date of the award.

 

On September 14, 2021, the Company issued 40,000 shares of common stock in connection with restricted stock awards, with a fair market value of $5.35 per share, from the date of the award.

 

On September 22, 2021, the Company issued a total of 12,437 common shares for the exercise of 14,200 options through a cashless exercise using 2,763 options for the $1.00 exercise price and in connection with a 1,000 restricted stock award.

 

21
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Stock Options

 

On August 24, 2021, the Company issued to Douglas Ellenoff, Chief Business Development Strategist, 300,000 options which are fully vested, to purchase its common stock. The Company will issue an additional 150,000 options per year for the next three years which will be fully vested at the end of each year, as long as Mr. Ellenoff remains employed by the Company. During the next three years, Mr. Ellenoff will be eligible to receive an additional 250,000 per year on each of the first three anniversaries of the commencement of his employment if during each such year Mr. Ellenoff introduces the Company to twelve (12) or more potential Business Transactions (as defined in the Ellenoff Agreement and which transactions need not be consummated); provided that the Company’s Chief Executive Officer may, in his sole discretion, waive the vesting requirement in any given year. Such options have an exercise price of $5.35 per share and will terminate 5 years after they vest.

 

Also on August 24, 2021, the Company granted 25,000 options to Paul R Thomson, its Executive Vice President and current Chief Financial Officer. The options were issued outside of the Company’s 2020 Equity Incentive Plan and are not governed by the 2020 Plan. The options have an exercise price of $5.35 per share, vest immediately, and have a term of five years.

 

The 325,000 options granted were valued on the grant date at approximately $3.24 per option or a total of $1,053,064 using a Black-Scholes option pricing model with the following assumptions: stock price of $5.37 per share (based on the closing price of the Company’s common stock of the date of issuance), volatility of 75.25%, expected term of 5 years, and a risk-free interest rate of 0.28%. In connection with the above stock option grant, for the nine months ended September 30, 2021, the Company recorded stock-based compensation of $1,053,064.

 

A summary of the status of the Company’s outstanding stock options and changes during the nine months ended September 30, 2021 is as follows:

  

Number of

Options

  

Weighted

Average Exercise

Price

  

Weighted

Average

Remaining

Contractual

Life

(Years)

 
Balance at January 1, 2021   600,009   $2.35    9.91 
Granted   325,000    -    - 
Exercised   19,200    -    - 
Forfeited   (917)   -    - 
Cancelled   (50,000)   -    - 
Balance outstanding at September 30, 2021   854,892   $3.30    7.54 
Options exercisable at September 30, 2021   854,892   $3.30    7.54 

 

Restricted Stock Awards

 

On August 24, 2021, in connection with Paul R. Thomson employment as Executive Vice President, and currently Chief Financial Officer, and as a material inducement to enter into the Thomson Agreement, Mr. Thomson received a restricted stock grant of 25,000 shares of Common Stock, 10,000 of which vest immediately, and the remaining 15,000 of which will vest at the rate of 5,000 shares at the end of each of the next three annual anniversaries of his employment. These equity awards to Mr. Thomson were issued outside of a shareholder approved stock or option plan pursuant to the Nasdaq “inducement grant” exception (Nasdaq Listing Rule 5635(c)(4)). On October 7, 2021, the Board of Directors of the Company (the “Board”) appointed Paul R. Thomson, the Executive Vice President of the Company, to the additional position of Chief Financial Officer of the Company effective October 9, 2021.

 

Also on August 24, 2021, under the terms of the Ellenoff Agreement, Douglas Ellenoff, Chief Business Development Strategist, will receive, in lieu of cash compensation: (i) a restricted stock award of 100,000 shares of Common Stock of the Company, 40,000 of which were issued after the execution of the Ellenoff Agreement and vest immediately, and the remaining 60,000 of which will be issued and vest at the rate of 20,000 shares at the end of each of the next three annual anniversaries of his employment, provided that Mr. Ellenoff serves on the Board at any time during such year; These equity awards to Mr. Ellenoff were material to induce Mr. Ellenoff to enter into the Ellenoff Agreement and were issued outside of a shareholder approved stock or option plan pursuant to the Nasdaq “inducement grant” exception (Nasdaq Listing Rule 5635(c)(4)).

 

In connection to the above awards for the issuance of 50,000 common shares, the Company has recorded stock-based compensation of $268,500 for the nine months ended September 30, 2021, based on stock price of $5.37 per share (the closing price of the Company’s common stock of the date of issuance).

 

For the three and nine months ended September 30, 2021, the Company recorded total stock-based compensation for the awards and options granted of $1,321,564. For the three and nine months ended September 30, 2020, the Company recorded stock-based compensation of $130,400.

 

NOTE 13 - RELATED PARTY TRANSACTIONS

 

As of September 30, 2021, the $67,273 due to related parties was comprised of; accrued salary due to David Phipps of $17,227, accrued salary and expenses due to Charles M. Fernandez of $37,237, accrued salary and expenses due to Sarwar Uddin, Theresa Carlise and Paul Thomson of $3,771, $3,740 and $5,298, respectively. Total related party payments due as of September 30, 2021, and December 31, 2020, are $67,273 and $102,060, respectively. These related party payables were non-interest bearing and have been repaid in full.

 

The Company’s UK subsidiary, GTC has an over-advance line of credit with HSBC, for working capital needs. The over-advance limit is £25,000 or $33,566 at an exchange rate of 1.34262, with interest at 3.95% over Bank of England’s base rate or current rate of 4.05% variable. The advance is guaranteed by David Phipps, the Company’s Chief Executive Officer. The Company has an American Express account for Orbital Satcom Corp. and an American Express account for GTC, both in the name of David Phipps who personally guarantees the balance owed.

 

22
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

The Company employs three individuals who are related to Mr. Phipps. The individuals earned gross wages totaling $107,042 and $58,149, for the nine months ended September 30, 2021 and 2020, respectively.

 

NOTE 14 - COMMITMENTS AND CONTINGENCIES

 

COVID-19

 

In March 2020, the World Health Organization declared the outbreak of a novel coronavirus (“COVID-19”) a global pandemic prompting government-imposed quarantines, suspension of in-person attendance of academic programs, and cessation of certain travel and business closures. The United States has entered a recession as a result of the COVID-19 pandemic, which may prolong and exacerbate the negative impact on us. Although we expect the availability of vaccines and various treatments with respect to COVID-19 to have an overall positive impact on business conditions in the aggregate over time, the exact timing of these positive developments is uncertain. In December 2020, the United States began distributing two vaccines that, in addition to other vaccines under development, are expected to help to reduce the spread of the coronavirus that causes COVID-19 once they are widely distributed. If the vaccines prove less effective than currently understood by the scientific community and the United States Food and Drug Administration, or if there are problems with the acceptance, availability, timing or other difficulties with widely distributing the vaccines, the pandemic may last longer, and could continue to impact our business for longer, than we currently expect. In response to COVID-19, governmental authorities have implemented numerous measures to try to contain the virus, such as travel bans and restrictions, prohibitions on group events and gatherings, shutdowns of certain businesses, curfews, shelter in place orders and recommendations to practice social distancing. Although many governmental measures have had specific expiration dates, some of those measures have already been extended more than once, and there is considerable uncertainty regarding the duration of such measures and the implementation of any potential future measures, especially if cases increase again across the United States, with the potential for additional challenges resulting from the emergence of new variants of COVID-19, some of which may be more transmissible than the initial strain. Such measures have impacted, and may continue to affect, our workforce, operations, suppliers and customers. We reduced the size of our workforce following the onset of COVID-19 and may need to take additional actions to further reduce the size of our workforce in the future; such reductions incur costs, and we can provide no assurance that we will be able to rehire our workforce in the event our business experiences a subsequent recovery. We took steps to curtail our operating expenses and conserve cash. We may elect or need to take additional remedial measures in the future as the information available to us continues to develop, including with respect to our workforce, relationships with our third-party vendors, and our customers. There is no certainty that the remedial measures we have implemented to date, or any additional remedial steps we may take in the future, will be sufficient to mitigate the risks posed by COVID-19. Further, such measures could potentially materially adversely affect our business, financial condition and results of operations and create additional risks for us. Any escalation of COVID-19 cases across many of the markets we serve could have a negative impact on us. Specifically, we could be adversely impacted by limitations on our employees to perform their work due to illness caused by the pandemic or local, state, or federal orders requiring our stores to close or employees to remain at home; limitation of carriers to deliver our product to customers; product shortages; limitations on the ability of our customers to conduct their business and purchase our products and services; and limitations on the ability of our customers to pay us in a timely manner. These events could have a material, adverse effect on our results of operations, cash flows and liquidity.

 

The ultimate magnitude of COVID-19, including the full extent of the material negative impact on our financial and operational results, will depend on future developments. The resumption of our normal business operations may be delayed or constrained by lingering effects of COVID-19 on our customers, suppliers and/or third-party service providers. Furthermore, the extent to which our mitigation efforts are successful, if at all, is not currently ascertainable. Due to the daily evolution of the COVID-19 pandemic and the responses to curb its spread, we cannot predict the full impact of the COVID-19 pandemic on our business and results of operations, but our business, financial condition, results of operations and cash flows have already been materially adversely impacted, and we anticipate they will continue to be adversely affected by the COVID-19 pandemic and its negative effects on global economic conditions. Any recovery from the COVID-19 pandemic and related economic impact may also be slowed or reversed by a variety of factors, such as any increase in COVID-19 infections. Even after the COVID-19 pandemic has subsided, we may continue to experience adverse impacts to our business as a result of its national and, to some extent, global economic impact, including the current recession and any recession that may occur in the future.

 

The success of our business depends on our global operations, including our supply chain and consumer demand, among other things. As a result of COVID-19, we have experienced shortages in inventory due to manufacturing issues, a reduction in the volume of sales in some parts of our business, such as rental sales and direct website sales, and a reduction in personnel due to lockdown related issues. Our results of operations for the nine months ended September 30, 2021 and for the year ended December 31, 2020, reflect this impact; however, we expect that this trend may continue, and the full extent of the impact is unknown. In recent months, some governmental agencies in the US and Europe, where we produce the largest percentage of our sales, have lifted certain restrictions. However, if customer demand continues to be low, our future equipment sales, subscriber activations and sales margin will be impacted.

 

Employment Agreements

 

Phipps Employment Agreement

  

On June 5, 2021, the Board caused the Company to enter into a new three-year employment agreement with David Phipps, effective June 2, 2021 (“Phipps Agreement”). The Phipps Agreement replaced his then existing employment agreement and has an initial term of three years. The Phipps agreement will be automatically extended for additional one-year term thereafter unless terminated by the Company or Mr. Phipps by written notice. Mr. Phipps’ annual base compensation is an aggregate of $350,000. The Company may increase (but not decrease his compensation during its term. In addition, Mr. Phipps will be entitled to receive an annual cash bonus if the Company meets or exceeds criteria adopted by the Compensation Committee of the Board of Directors. Mr. Phipps is also entitled to participate in any other executive compensation plans adopted by the Board of Directors, and is eligible for such grants of awards under stock option or other equity incentive plans as the Compensation Committee of the Company may from time to time determine (the “Share Awards”). Share Awards will be subject to the applicable Plan terms and conditions, provided, however, that Share Awards will be subject to any additional terms and conditions as are provided herein or in any award certificate(s), which shall supersede any conflicting provisions governing Share Awards provided under the equity incentive plan. The Company is required to pay or to reimburse Mr. Phipps for all reasonable out-of-pocket expenses actually incurred or paid by him in the course of his employment, consistent with the Company’s policy. Mr. Phipps will be entitled to participate in such pension, profit sharing, group insurance, hospitalization, and group health and benefit plans and all other benefits and plans, including perquisites, if any, as the Company provides to its senior employees. The Phipps Agreement may be terminated based on death or disability of Mr. Phipps, for cause or without good reason, for cause or with good reason, and as a result of the change of control of the Company. The Phipps Agreement also contains certain provisions that are customary for agreements of this nature, including, without limitation, non-competition and non-solicitation covenants, indemnification provisions, etc. On August 7, 2021, the Phipps Agreement was amended in order to, among other things, (i) change Mr. Phipps’ title to “President of Orbsat Corp and Chief Executive Officer of Global Operations” and (ii) to increase Mr. Phipps’s compensation by providing for an auto allowance $1,000 a month.

 

23
 

 

ORBSAT CORP AND SUBSIDIARIES

FKA: ORBITAL TRACKING CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

Fernandez May Employment Agreement

 

On May 23, 2021, the Company entered into a three (3) year Employment Agreement (the “May Agreement”) with Mr. Fernandez to serve as Chairman of the Board. Such agreement includes provision for automatic one (1) year extensions. Mr. Fernandez’s employment will commence on the later of our receipt of an approval for listing letter from Nasdaq and the effectiveness of the registration statement. As compensation for services under the May Agreement, was to receive, in monthly installments during the Term, the sum of $12,000. Mr. Fernandez was also be entitled to such cash bonus opportunity and equity compensation arrangements as the Compensation Committee may determine following the effectiveness of this registration statement. The May Agreement also provides for the Company to reimburse Mr. Fernandez for any and all premium payments made by him to obtain and continue in full force and effect throughout the entire period of employment personal catastrophe and disability insurance coverages for Mr. Fernandez. Such insurance shall be obtained through any insurance carrier of Mr. Fernandez’s choosing, and shall have premium limits not to exceed one hundred percent (100%) of Mr. Fernandez’s Base Salary per annum. In addition, Mr. Fernandez will be entitled to participate in such pension, profit sharing, group insurance, hospitalization, and group health and benefit plans and all other benefits and plans, including perquisites, if any, as the Company provides to its senior Executives. Under the agreement, the Company is also obligated to reimburse Mr. Fernandez for up to $10,000 per year related to Mr. Fernandez’s business and personal travel and/or that of his immediate family members, as well as up to $10,000 per year for professional fees incurred by Mr. Fernandez, whether in connection with Mr. Fernandez’s association with the Company or otherwise. In connection to the June Offering, the Company granted Mr. Fernandez an award of restricted stock with a grant date fair value equal to $3,000,000 determined at the per unit offering price (the “RSA”), which RSA will vest 1/3 at each of the three anniversaries of the grant date. Notwithstanding the vesting schedule, full vesting will occur upon a Change in Control, as that term is defined in the RSA. The Company at its sole expense is obligated to register the reoffer and resale by Mr. Fernandez of the securities granted to Employee pursuant to the RSA.

 

Fernandez June Employment Agreement

 

On June 2, 2021, the Company entered into a new employment agreement (the “June Agreement”) with Charles M. Fernandez, with an initial term of 5 years effective on May 28, 2021. The June Agreement replaced “the May Agreement”. Under the June Agreement, Mr. Fernandez will serve as the Chairman and Chief Executive Officer of the Company. The June Agreement will be automatically extended for additional one-year terms unless terminated by the Company or Mr. Fernandez by written notice. Mr. Fernandez’s annual base compensation under the June Agreement is $350,000 per year. The Company may increase (but not decrease) his compensation during the June Agreement’s term. In addition, Mr. Fernandez is entitled to receive an annual cash bonus if the Company meets or exceeds criteria adopted by the Compensation Committee of the Board. Mr. Fernandez is also entitled to participate in any other executive compensation plans adopted by the Board, and is eligible for such grants of Share Awards. Share Awards will be subject to the applicable Plan terms and conditions, provided, however, that Share Awards will be subject to any additional terms and conditions as are provided therein or in any award certificate(s), which will supersede any conflicting provisions governing Share Awards provided under the equity incentive plan. The Company is required to pay or to reimburse Mr. Fernandez for all reasonable out-of-pocket expenses actually incurred or paid by Mr. Fernandez in the course of his employment, consistent with the Company’s policy.

 

Mr. Fernandez will also be entitled to participate in such pension, profit sharing, group insurance, hospitalization, and group health and benefit plans and all other benefits and plans, including perquisites, if any, as the Company provides to its senior employees. The June Agreement may be terminated based on death or disability of Mr. Fernandez, for cause or without good reason, for cause or with good reason, as a result of the change of control of the Company and at the option of Mr. Fernandez with or without cause. The June Agreement also contains certain provisions that are customary for agreements of this nature, including, without limitation, non-competition and non-solicitation covenants, indemnification provisions, etc.

 

24
 

 

The Company will also reimburse Mr. Fernandez for any and all premium payments made by him to obtain and continue personal catastrophe and disability insurance coverages for himself, which policy will have policy limits not to exceed one hundred percent (100%) of his base salary per annum at any given time. In addition, the Company will pay for any and all travel-related expenses incurred by Mr. Fernandez and/or his immediate family members, not to exceed $10,000.00 per fiscal year, regardless of whether or not such expenses are incurred by Mr. Fernandez in connection with services or duties to be performed by him as an employee of the Company. The Company will also pay for any and all fees and costs incurred by Mr. Fernandez in connection with professional services provided to him, not to exceed $10,000 per year, including, without limitation, services provided to the Company by attorneys, accountants, financial planners and the like, regardless of whether or not such services are provided to Mr. Fernandez in connection with his employment with the Company.

 

In addition, the June Agreement (which repeats, but not duplicates, a grant of restricted stock made under the May Agreement), Mr. Fernandez received an award of restricted stock with a grant date fair value equal to $3,000,000 determined at the per unit offering price in the June Offering ($5 per Unit) (the “RSA”), which RSA will vest 1/3 at each of the three anniversaries of the grant date. The Grant Date for the RSA is May 28, 2021, as determined pursuant to the May Agreement. Notwithstanding the vesting schedule, full vesting will occur upon a Change in Control, as that term is defined in the Restricted Stock Agreement pursuant to which the RSA was made. The Company at its sole expense is obligated to register the reoffer and resale by Mr. Fernandez of the securities granted to him pursuant to the Restricted Stock Agreement.

 

If Mr. Fernandez’ employment is terminated for any reason at any time by the Company prior to the full vesting of the RSA without “Cause” (as that term is defined in the June Agreement), the RSA will vest and Mr. Fernandez will receive all right, title and interest in the balance of the securities granted to him in the RSA.

 

During the term of the June Agreement and so long as Mr. Fernandez is employed by the Company, he may nominate two directors to the Company’s Board of Directors. The appointment of these directors to the Board is subject to approval by the Board of Directors.

 

On August 7, 2021, the June Agreement was amended in order to, among other things, increase Mr. Fernandez’s compensation by (i) providing for medical plan coverage for Mr. Fernandez and his family at the expense of the Company, and (ii) providing for an auto allowance $1,000 per month.

 

Uddin Employment Agreement

 

On June 22, 2021, the Company appointed Sarwar Uddin as the Chief Financial Officer of the Company. Mr. Uddin replaced Thomas Seifert, whose employment by the Company terminated on the same date. The initial term of Mr. Uddin’s agreement is one year commencing on June 22, 2021. The term of the employment agreement will be automatically extended for additional one-year terms unless terminated by the Company or Mr. Uddin by written notice. Mr. Uddin’s annual base compensation is $240,000. The Company may increase (but not decrease) his compensation during its term. In addition, Mr. Uddin will be entitled to receive an annual cash bonus if the Company meets or exceeds criteria adopted by the Compensation Committee of the Board of Directors. Mr. Uddin is also entitled to participate in any other executive compensation plans adopted by the Board of Directors and is eligible for such grants of awards under stock option or other equity incentive plans as the Compensation Committee of the Company may from time to time determine (the “Share Awards”). The Company is required to pay or to reimburse Mr. Uddin for all reasonable out-of-pocket expenses actually incurred or paid by Mr. Uddin in the course of his employment, consistent with the Company’s policy. Mr. Uddin shall be entitled to participate in such pension, profit sharing, group insurance, hospitalization, and group health and benefit plans and all other benefits and plans, including perquisites, if any, as the Company provides to its senior Employees. The employment agreement may be terminated based on death or disability of the executive, for cause or without good reason, for cause or with good reason, and as a result of the change of control of the Company. The employment agreement also contains certain provisions that are customary for agreements of this nature, including, without limitation, non-competition and non-solicitation covenants, indemnification provisions, etc. On August 7, 2021, on the approval and recommendation of the Compensation Committee of the Board of Directors of Orbsat Corp, the Company entered into an amendment to the current employment agreement to increase Mr. Uddin’s compensation by providing for an allowance of $600 per month for the payment of medical plan coverage for Mr. Uddin and his family.

 

On October 4, 2021, Sarwar Uddin, the Chief Financial Officer of Orbsat Corp (the “Company”), notified the Company of his resignation from all positions he holds with the Company. Mr. Uddin’s resignation will be effective as of the close of business on October 8, 2021.

 

25
 

 

Carlise Employment Agreement

 

On June 22, 2021, the Company appointed Theresa Carlise, Controller, Treasurer and Secretary. The initial term of Ms. Carlise agreement was one year. The term of the employment agreement will be automatically extended for additional one-year terms unless terminated by the Company or Ms. Carlise by written notice. Ms. Carlise’s annual base compensation is $180,000. The Carlise Agreement provides for medical plan coverage and an auto allowance. The Company may increase (but not decrease) her compensation during its term. In addition, Ms. Carlise will be entitled to receive an annual cash bonus if the Company meets or exceeds criteria adopted by the Compensation Committee of the Board of Directors. Ms. Carlise is also entitled to participate in any other executive compensation plans adopted by the Board of Directors and is eligible for such grants of awards under stock option or other equity incentive plans as the Compensation Committee of the Company may from time to time determine (the “Share Awards”). The Company is required to pay or to reimburse Ms. Carlise for all reasonable out-of-pocket expenses actually incurred or paid by Ms. Carlise in the course of her employment, consistent with the Company’s policy. Ms. Carlise shall be entitled to participate in such pension, profit sharing, group insurance, hospitalization, and group health and benefit plans and all other benefits and plans, including perquisites, if any, as the Company provides to its senior Employees. The employment agreement may be terminated based on death or disability of the executive, for cause or without good reason, for cause or with good reason, and as a result of the change of control of the Company. The employment agreement also contains certain provisions that are customary for agreements of this nature, including, without limitation, non-competition and non-solicitation covenants, indemnification provisions, etc. On August 7, 2021, on the approval and recommendation of the Compensation Committee of the Board of Directors of Orbsat Corp, the Company entered into an amendment to the current employment agreement. The Amendment for Ms. Carlise amends her Employment Agreement in order to, among other things, change Ms. Carlise’s title to “Chief Accounting Officer, Secretary and Treasurer. On October 8, 2021, on the approval and recommendation of the Compensation Committee, and following the subsequent approval of the Board, the Company entered into an amendment to the Company’s current employment agreement with Theresa Carlise, the Company’s Chief Accounting Officer, Treasurer and Secretary, to extend the initial term of her employment agreement from 1 year to 3 years (the “Carlise Amendment”).

 

Ellenoff Employment Agreement

 

On August 24, 2021, Douglas S. Ellenoff was appointed to the positions of Chief Business Development Strategist of Orbsat Corp (the “Company”) and Vice Chairman of the Board of Directors of the Company. The appointment was made on the approval and recommendation of the Nominating Committee of the Board. Mr. Ellenoff was not appointed to any committees of the Board.

 

In connection with Mr. Ellenoff’s appointment to the position of Chief Business Development Strategist of the Company, Mr. Ellenoff and the Company entered into a three-year Employment Agreement, dated August 24, 2021 (the “Ellenoff Agreement”), that sets forth the terms of his employment, including with regard to compensation. Under the Ellenoff Agreement, Mr. Mr. Ellenoff will be nominated and renominated to serve on the Board during the term of the agreement. Under the terms of the Ellenoff Agreement, Mr. Ellenoff will receive, in lieu of cash compensation: (i) a restricted stock award of 100,000 shares of Common Stock of the Company, 40,000 of which will be issued within 5 business days of the execution of the Ellenoff Agreement and vest immediately, and the remaining 60,000 of which will be issued and vest at the rate of 20,000 shares at the end of each of the next three annual anniversaries of his employment, provided that Mr. Ellenoff serves on the Board at any time during such year; and (ii) options to purchase a total of 1,500,000 shares of the Corporation’s Common Stock, 300,000 of which will issued within 5 business days of the execution of the Ellenoff Agreement and vest immediately, 150,000 of which will vest on each of the next three annual anniversaries of the commencement of his employment, and the remaining 750,000 of which will vest at the rate of 250,000 per year on each of the first three anniversaries of the commencement of his employment if during each such year Mr. Ellenoff introduces the Company to twelve (12) or more potential Business Transactions (as defined in the Ellenoff Agreement and which transactions need not be consummated); provided that the Company’s Chief Executive Officer may, in his sole discretion, waive the vesting requirement in any given year. Such options have an exercise price of $5.35 per share and will terminate 5 years after they vest. These equity awards to Mr. Ellenoff were material to induce Mr. Ellenoff to enter into the Ellenoff Agreement and were issued outside of a shareholder approved stock or option plan pursuant to the Nasdaq “inducement grant” exception (Nasdaq Listing Rule 5635(c)(4)).

 

Thomson Employment Agreement

 

On August 24, 2021, Paul R. Thomson was appointed to the position of Executive Vice President of the Company. Mr. Thomson’s appointment as Executive Vice President was effective on August 24, 2021, the date of that certain Employment Agreement between Mr. Thomson and the Company (the “Thomson Agreement”). The Thomson Agreement has an initial term of 3 years and will be automatically extended for additional 1-year term unless terminated by the Company or Mr. Thomson by written notice. Mr. Thomson’s annual base compensation is $250,000. The Company may increase (but not decrease) his compensation during its term. In addition, Mr. Thomson will be entitled to receive an annual cash bonus if the Company meets or exceeds criteria adopted by the Compensation Committee of the Board. Mr. Thomson is also entitled to participate in any other executive compensation plans adopted by the Board and is eligible for such grants of awards under stock option or other equity incentive plans as the Compensation Committee of the Company may from time to time determine (the “Share Awards”).

 

26
 

 

In connection with Mr. Thomson’s employment, and as a material inducement to enter into the Thomson Agreements, Mr. Thomson received (i) immediately vested options to purchase 25,000 shares of Common Stock at a per share price of $5.35, and having a term of 5 years; and (ii) a restricted stock grant of 25,000 shares of Common Stock, 10,000 of which vest immediately, and the remaining 15,000 of which will vest at the